CURRICULUM VITAE - 2019 BROOK KINGSTON BAKER

Professor of Law Northeastern University School of Law

416 Huntington Avenue Boston, MA 02115

(617) 373-3217 FAX (617) 373-5056

E-mail: b.baker@northeastern.edu Skype: brook_baker

EDUCATION: LAW SCHOOL: Northeastern University School of Law, J.D., 1976 COLLEGE: Harvard University, B.A. (cum laude) 1969 ACADEMIC AND LEGAL EXPERIENCE: 1995-present Professor of Law at Northeastern University School of Law

1989-2006 Director of Legal Practice Program 1989-1995 Assoc. Professor at Northeastern University School of Law 1987-1989 Full-time Lecturer at Northeastern University School of Law 1985-86 Senior Researcher and Lecturer at Northeastern University and Assistant

Director Skills and Advocacy Training of New York Department of Social Services Attorneys

1984-85 Full-time Visiting Professor at Northeastern University 1979-84 Part-time Visiting Assistant Professor of Law or Lecturer at Northeastern University 2005-present Program on Human Rights and the Global Economy – Affiliate 2015-present Co-director 2016- Center on Health Policy and Law – Affiliate 2016- Center for Law, Innovation & Creativity – Affiliate 2015- Civil Rights and Restorative Justice Project – Advisory Committee

2010-2015 Fulbright Specialist Candidate 2009-2018 Honorary Research Fellow, University of KwaZulu Natal, S. Africa, Faculty of Law Jan-May 2011 Sabbatical University of KwaZulu Natal, Durban S. Africa Jan-July 1997 Sabbatical University of Durban-Westville, Durban, S. Africa 1986-87 Visiting Ass’t Professor at Boston College Law School, Director Urban Legal Laboratory 1976-87 Associate and Of-Counsel, Law Offices of [Shubow,] Stahlin & Bergstresser, Inc. HIV-RELATED COMMUNITY SERVICE POSITIONS AND EXPERIENCE: Health GAP (Global Access Project) Senior Policy Analyst 2001-present, Chairperson 2007-2010, Board Member 2007- Expert Advisor to UNDP as Secretariat to The United Nation Secretary-General’s High-Level Panel on Health Technologies: Promoting Innovation and Access 2015-16 Member Technical Working Group of the Equitable Access Initiative 2015-16 NGOs Board Member, Unitaid Executive Board 2015-2017 Vice Chair, Finance and Accountability Committee 2015-2017 Governance Committee 2015-2017

2

NGOs Alternate Board Member, Unitaid Executive Board 2013-2014 NGOs Delegation to Unitaid, Contact Group Member 2008-2013 NGOs Delegation to Unitaid, Key Advisor 2017- Northern NGO Delegation to the Global Fund to Fight AIDS, Tuberculosis and Malaria: Consultant Group 2007-present Health Workforce Advocacy Initiative, Steering Committee 2007-2013 Global Health Workforce Alliance, Working Group for the Alliance strategy for galvanizing members and partners 2012 Boston Global Action Network – Africa AIDS Project, Founder 2000-02 I. AIDS RELATED PUBLICATIONS AND ACTIVITIES – pp. 2-40 II. LEGAL EDUCATION RELATED PUBLICATIONS AND ACTIVITIES – pp. 40-49 I. AIDS-RELATED PUBLICATIONS AND ACTIVITIES Aids-Related Publications

A Sliver of Hope: Analyzing Voluntary Licenses for Medicines, 10 NORTHEASTERN U. L. REV. 226-315 (2018) https://poseidon01.ssrn.com/delivery.php?ID=645078002070014005010000102029116064049002040059035036071126118006005087004071017091100000007125053063114121083106076025090064033029000036017105123030082090023119042036052067068078003024022079094092028094084075111067115089010086070116066120108017084&EXT=pdf

Adam Gaffney, Joel Lexchin & the US/Canadian Pharmaceutical Policy Reform Working Group [Brook Baker member], Healing an Ailing Pharmaceutical System: A Prescription for Reform, 361 BMJ 1039 (2018) https://www.bmj.com/content/bmj/361/bmj.k1039.full.pdf Brook K. Baker & Katrina Geddes, The Incredible Shrinking Victory: Eli Lilly v. Canada, Success, Judicial Reversal, and Continuing Threats from Pharmaceutical ISDS, 49 LOYOLA CHICAGO L.J. 479-513 (2017) https://www.luc.edu/media/lucedu/law/students/publications/llj/pdfs/vol-49/issue-2/13_Baker.pdf

Ellen ‘t Hoen, Pascale Boulet & Brook K. Baker, Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation, 10 J. PHARMACEUTICAL POLICY & PRACTICE (June 2017) DOI 10.1186/s40545-017-0107-9, http://rdcu.be/tMrd

The Battle for Access to Medicines for All, 389 LANCET 355-56 (2017) http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(17)30153-8.pdf Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere, PLOS MEDICINE DOE:10.1371/journal.pmed.1001970 (2016) http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001970 Brook K. Baker & Katrina Geddes, ISDS, Intellectual Property Rights and Public Health in RETHINKING BILATERAL INVESTMENT TREATIES: CRITICAL ISSUES AND POLICY CHOICES, 189-99 (Kavaljit Singh & Burghard Ilge eds., 2016) http://www.madhyam.org.in/wp-content/uploads/2016/03/Rethinking-BIT-Book-PDF-15-March-2016.pdf

3

International Collaboration on IP and Access to Medicines: The Birth of the S. Africa Fix the Patents Law Campaign, 60 NYLS L. REV. 309-343 (2015-16) https://poseidon01.ssrn.com/delivery.php?ID=628003127096099108086064120094067024029024036061084064120096102030085006101073029104060110030124042026061122122126126095019124126034071019079105115107090114083076072083046073103089086026110069022093110126126015081102071090093012003076115120080106009&EXT=pdf Brook K. Baker & Katrina Geddes, Corporate Power Unbound: Investor-State Arbitration of IP Monopolies on Medicines – Eli Lilly v. Canada and the Trans-Pacific Partnership Agreement 23 J. INTEL. PROP. L. 1-59 (2015) http://digitalcommons.law.uga.edu/cgi/viewcontent.cgi?article=1249&context=jipl

TPP = Transnational Pharmaceutical Profiteering: Big Pharma’s Monopolies Strengthen and Multiply in Trans Pacific Partnership Trade Agreements, 303/304 Third World Resurgence 24 (Nov./Dec. 2015) http://www.twn.my/title2/resurgence/2015/303-304/cover03.htm Matthew Kavanagh, Jennifer Cohn, Lynette Mabote, Benjamin M. Meier, Brian Williams, Asia Russell, Kenly Sikwese, Brook K. Baker, Evolving Human Rights and the Science of Antiretroviral Medicine, 17/1 HEALTH & HUMAN RIGHTS J. 47-61 (2015) http://www.hhrjournal.org/2015/06/04/evolving-human-rights-and-the-science-of-antiretroviral-medicine/ Srividhya Ragavan, Sean Flynn & Brook Baker, Justifying India’s patent position to the United States International Trade Commission and Office of the United States Trade Representative, 7 INDIAN J. INTEL. PROP. L. 1-28 (2014-15) Will the Modi government succumb to US and industry pressure to modify its pro-access pharmaceutical patent policy?, 25:6 EXPERT OPIN. THER. PATENTS 1-4 (2015) Debunking IP-for-Development: Africa Needs IP Space Not IP Shackles in INTERNATIONAL ECONOMIC LAW AND AFRICAN DEVELOPMENT, 82-110 (Laurence Boulle, Emmanuel Laryea & Franziska Sucker eds. 2014) Matthew M. Kavanagh & Brook K. Baker, Comment: Governance and Transparency at PEPFAR, 2 LANCET GLOBAL HEALTH e13-14 (2014) http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(13)70152-9/fulltext Threat of Pharmaceutical-Related IP Investment Rights in the TPP: An Eli Lilly v. Canada Case Study, 4:4 INVESTMENT TREATY NEWS 8-10 (2013) http://www.iisd.org/pdf/2013/iisd_itn_sept_2013_en.pdf Roundtable: Empowering patients and strengthening communities for real health workforce and funding targets, 91 BULL. WORLD HEALTH ORG. 889 (2013) http://www.who.int/bulletin/volumes/91/11/13-126896.pdf Corporate Power Unbound: Investor-State Arbitration of IP Monopolies on Medicines – Eli Lilly and the TPP, PIJIP RESEARCH PAPER SERIES, Paper 36 (2013) http://digitalcommons.wcl.american.edu/cgi/viewcontent.cgi?article=1038&context=research Northeastern University School of Law Research Paper No. 139-2013 http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2266507 Yousuf Vawda & Brook Baker, Achieving Social Justice in the Intellectual Property Debate: Realising the Goal of Access to Medicines, 13 AFRICA HUMAN RIGHTS L. J. 57-84 (2013) http://www.ahrlj.up.ac.za/images/ahrlj/2013/ahrlj_vol13_no1_2013_vawda_baker.pdf

4

Sean Flynn, Brook Baker, Margot Kaminski, Jimmy Koo, U.S. Proposal for an Intellectual Property Chapter in the Trans-Pacific Partnership Agreement, 28 AM. U. INT’L L. REV. 105-202 (2012) (principal author Part III) http://digitalcommons.wcl.american.edu/cgi/viewcontent.cgi?article=1023&context=research Settlement of India/EU WTO Dispute re Seizures of In-Transit Medicines: Why the Proposed EU Border Regulation Isn’t Good Enough, PIJIP RESEARCH PAPER SERIES (2012) http://digitalcommons.wcl.american.edu/cgi/viewcontent.cgi?article=1026&context=research Sean Flynn, Margot Kaminski, Brook Baker, Jimmy Koo, Public Interest Analysis of US TPP Proposal for an IP Chapter, PIJIP Research Paper Series, Paper 21 (2011) http://digitalcommons.wcl.american.edu/cgi/viewcontent.cgi?article=1023&context=research Jen Cohn, David Holtzman & Brook K. Baker, Efficiencies in AIDS Programming: The Rhetoric and the Realities, 58 J. AIDS 228-31 (2011) http://journals.lww.com/jaids/Fulltext/2011/11010/Efficiencies_in_AIDS_Programming___The_Rhetoric.1.aspx ACTA: Risks of Third-Party Enforcement to Access to Medicines, 26 AM. U. INT’L L. REV. 579-599 (2011) http://www.auilr.org/pdf/26/26.3.3.pdf Jennifer Cohn, Asia Russell, Brook K. Baker, Alice Kayongo, Esther Wanjiku, Jael Amati, Paul Davis, Using Global Health Initiatives to Strengthen Health Systems: A Civil Society Perspective, 6 GLOBAL PUBLIC HEALTH 1-16 (2011) http://dx.doi.org/10.1080/17441692.2010.521165 Letter – Effect of development assistance on domestic health expenditures, 376 LANCET 589-590 (2010) http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)61289-5/fulltext?elsca1=TL-210810&elsca2=email&elsca3=segment

The Impact of the International Monetary Fund’s Macroeconomic Policies on the AIDS Pandemic, 40 INT’L J. HEALTH SERVICES 347-363 (2010) http://people.pwf.cam.ac.uk/ds450/details/40_3p.pdf Jennifer Cohn & Brook K. Baker, Obstacles and Opportunities on the Road to Universal Access to ARVs, 7 CURRENT HIV/AIDS REPORTS 161-167 (2010) http://infojustice.org/download/gcongress/access_to_medicines:_tpp,_acta,_and_eu_border_regulation/cohn%20article.pdf WHO Positive Synergies Civil Society Research Group, Interactions Between Global Health Initiatives and Health Systems – Evidence from Countries (2009) http://www.who.int/healthsystems/publications/MPS_civil_society_case_studies.pdf Patents, Pricing, and Access to Essential Medicines in Developing Countries, 11 AMA J. ETHICS – VIRTUAL MENTOR 527-32 (July 2009) http://virtualmentor.ama-assn.org/2009/07/pfor1-0907.html World Health Organization Maximizing Positive Synergies Collaborative Group, An Assessment of interactions between global health initiatives and country health systems, 373 LANCET 2137-69 (June 20, 2009) Brook K. Baker & Eva Ombaka, Viewpoint – The Danger of Drug Donations (In-Kind Contributions) To the Global Fund – Adverse Market and Therapeutic Effects, 373 LANCET 1218-21 (2009) Ending drug registration apartheid – taming data exclusivity and patent/registration linkage, 34 AM. J. LAW & MED. 303-344 (2008) http://journals.sagepub.com/doi/pdf/10.1177/009885880803400209

5

David McCoy, Sara Bennett, Sophie Witter, Bob Pond, Brook Baker, Jeff Gow, Sudeep Chand, Tim Ensor, Barbara McPake, Gavin George, Health worker salaries and incomes in sub-Saharan Africa, 371 LANCET 675-681 (2008) Gorik Ooms, Wim Van Damme, Brook K. Baker, Paul Zeitz, Ted Schrecker, “The ‘diagonal’ approach to Global Fund financing: a cure for the broader malaise of health systems? 4 GLOBALIZATION & HEALTH 6 (2008) http://www.globalizationandhealth.com/content/pdf/1744-8603-4-6.pdf

Placing Access to Medicines on the Human Rights Agenda in THE POWER OF PILLS: SOCIAL, ETHICAL & LEGAL ISSUES IN DRUG DEVELOPMENT, MARKETING & PRICING, 239-248 (Jillian Clare Cohen, Patricia Illingsworth & Edo Schüklenk eds., 2006).

Arthritic Flexibilities for Accessing Medicines, Analysis of WTO Action Regarding Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, 14 IND. INT’L & COMP. L. REV. 613-715 (2004) https://mckinneylaw.iu.edu/iiclr/pdf/vol14p613.pdf Teaching Legal Skills in South Africa: A Transition from Cross-Cultural Collaboration to International HIV/AIDS Solidarity, 9 J. LEGAL WRITING INST. 145-183 (2003).

Commissioned papers:

MSF Voluntary Licenses & Public health Guide Short Paper Series (2018) No. 1 – Overview

No. 2 – Territorial Coverage and Access Implications No. 3 – Registration-Related Issues in Voluntary Licenses No. 4 – Government Regulation of Voluntary Licenses

UNDP & Government of Malawi, Meeting Report – High Level Meeting: Promoting Policy Coherence on Health Technology Innovation & Access in the ARIPO Region, (commissioned Nov. 2017) The Secretary-General’s High-Level Panel on Health Technologies: Promoting Innovation and Access, Background Paper: Existing work, initiatives and proposals to improve innovation and access to medical technologies (commissioned March 2016) https://static1.squarespace.com/static/562094dee4b0d00c1a3ef761/t/56da11782b8dde9c3d5865b4/1457132156145/DRAFT+Background+Paper+on+Existing+and+prior+work+initiatives+and+propo+++.pdf The Secretary-General’s High-Level Panel on Health Technologies: Promoting Innovation and Access, Draft Criteria for Assessing Proposals, UNDP (commissioned Dec. 2015) INDONESIA DRAFT PATENT LAW 2015 REVIEW AND RECOMMENDATIONS, UNDP (commissioned 2015) Study on the Implications of the New Status of Kenya as a Middle-Income Country on Sustainability of the National HIV and AIDS Response: Intellectual Property Component (March 2, 2015, commissioned by Gov. of Kenya & UNAIDS/WHO) Brief Comments on Amended Draft Model Law on Medical Products Regulation and Harmonization in Africa, Comments Received Thus Far, and Draft Regulations, UNDP (commissioned 2014)

INDONESIA PATENT LAW REVIEW AND RECOMMENDATIONS, UNDP (commissioned 2014)

6

Boyan Konstantinov & Brook Baker, TREATING MORE FOR LESS? A DISCUSSION PAPER EXPLORING THE PATENT STATUS, REGISTRATION AND PRICE OF SELECT HIV MEDICINES IN EASTERN EUROPE AND CENTRAL ASIA, UNDP (commissioned 2014) Review of Africa Union Draft Preliminary Model Law on Medicines Registration and Harmonization (with Yousuf Vawda and Andy Gray, commissioned paper) (July 10, 2013) Brook K. Baker & Tenu Avafia, THE EVOLUTION OF IPRS FROM HUMBLE BEGINNINGS TO THE MODERN DAY TRIPS-PLUS ERA: IMPLICATIONS FOR TREATMENT ACCESS, UNDP/UNAIDS Global Commission on HIV and the Law (commissioned June 2011) http://www.hivlawcommission.org/index.php/working-papers?start=10 Tenu Avafia & Brook K. Baker, BACKGROUND PAPER: LAWS AND PRACTICES THAT FACILITATE OR IMPEDE HIV-RELATED TREATMENT ACCESS, UNDP/UNAIDS Global Commission on HIV and the Law (commissioned Sept. 2010) http://www.hivlawcommission.org/index.php/background-papers Background Paper: Global Fund CS/PS Pre-Consultation on the Joint Health System Strengthening Platform, 27-28 January 2010, Geneva Civil Society Options Paper on Community System Strengthening, Meeting Report: Increasing Civil Society Impact on the Global Fund to Fight AIDS, Tuberculosis and Malaria: Strategic Options and Deliberations, 5-7 January 2007 http://www.icaso.org/resources/CS_Report_Policy_Paper_Jan07.pdf Drug Registration Barriers and Logjams, in MISSING THE TARGET #5: IMPROVING AIDS DRUG ACCESS AND ADVANCING HEALTH CARE FOR ALL, 49-58 (ITPC Dec. 2007) http://www.aidsdatahub.org/sites/default/files/documents/2007_Improving_AIDS_Drug_Access_and_Advancing_Health_Care_for_All.pdf.pdf PROCESSES AND ISSUES FOR IMPROVING ACCESS TO MEDICINES: WILLINGNESS AND ABILITY TO UTILIZE TRIPS FLEXIBILITIES IN NON-PRODUCING COUNTRIES, U.K. Dept. for Int’l Development, Health Systems Resource Centre (Commissioned Sept. 2004) http://www.iprsonline.org/resources/docs/Baker_TRIPS_Flex.pdf WORKING PAPER: ANALYSIS AND RESPONSE TO RECENT WTO ACTION REGARDING TRIPS AGREEMENT AND PUBLIC HEALTH, United Nations Millennium Development Goals Project, Task Force 5: Infectious Diseases and Access to Essential Medicines (Commissioned Dec. 2003).

2018 Policy papers/analyses, media:

MPP-AbbVie License on Glecaprevir and Pibrentasvir (G/P): Backtracking on Geographic Coverage but with Options for Oppositions, Compulsory Licenses, and Negotiated Territorial Expansion, Health GAP (Nov. 13, 2018) https://www.healthgap.org/mpp_abbvie_license_on_glecaprevir_and_pibrentasvir_g_p_backtracking_on_geographic_coverage_but_with_options_for_oppositions_compulsory_licenses_and_negotiated_territorial_expansion The President’s Trumpeteering on Drug Prices is Really a Toy Whistle, Health GAP (Oct. 26, 2018) https://www.healthgap.org/the_president_s_trumpeteering_on_drug_prices_is_really_a_toy_whistle Unitaid: Becoming even more proactively engaged in overcoming registration related barriers (Oct. 1, 2018)

7

Wink, Wink: Pfizer agrees to roll back price hikes, INFOJUSTICE (July 13, 2018), http://infojustice.org/archives/40140 Misleading Ab”Use” of Percentages in Drug Price Escalation, INFOJUSTICE (July 5, 2018), http://infojustice.org/archives/40138 Comments: Malawi Patent Law Reform – WIPO Submission (June 8, 2018) Submission: Global Dialogue: HIV, Rights and Law in the Era of 2030 Agenda for Sustainable Development (May 15, 2018) Blog: Drug Companies Getting Away with Murder - Trump's Solution: Round Up Foreign Country Targets (May 11, 2018) https://www.healthgap.org/drug_companies_getting_away_with_murder_trump_s_solution_find_some_more_foreign_targets Blog: Lies, Distortions, and False Promises: The U.S. Position on Compulsory Licenses in the 2018 Special 301 Report (May 1, 2018) http://infojustice.org/archives/39888 & https://www.healthgap.org/lies_distortions_and_false_promises_the_u_s_position_on_compulsory_licenses_in_the_2018_special_301_report; Spanish translation: http://blogs.eltiempo.com/medicamentos-sin-barreras/2018/10/01/mentiras-distorsiones-falsas-promesas-posicion-los-ee-uu-materia-licencias-obligatorias-informe-especial-301-2018/ Blog: Don’t Be Afraid of Compulsory Licenses Despite US Threats: Special 301 Reports 1998-2017 – Listing Concerns but Taking Little Action (February 20, 2018) http://infojustice.org/archives/39594

2018 Presentations, Expert Consultations, and Trainings Fireside Chat with Prof. Brook Baker in honor of World AIDS Day: On the Topic of HIV/AIDS Advocacy, Access, and Care, Northeastern University Global Health Initiative (Dec. 7. 2018) Workshop 1: Mobilizing for More: Fighting for Equitable HIV/AIDs Healthcare, Global Health Initiative Conference, Northeastern University (Oct. 19-20, 2018) Strategy Retreats, Health GAP (Global Access Project), San Juan, Puerto Rico, and New York City (Oct. 4-7 and Oct. 13-14, 2018) 5th Global Congress on Intellectual Property and the Public Interest, Washington College of Law, Washington DC (Sept. 27-29, 2018)

Panel: Challenging Unmerited Patents: Transparency and Collective Action for Access to Medicines Panel: Access to Medicine in Least Developed Countries Panel Organizer and Presenter: Lesson Learned and Improving Strategies for Voluntary and Compulsory Licenses to Increase Access to Appropriate and Affordable Medicines

Presentation: Medicines Patent Pool: Accelerating Aggregated Markets for Affordable, Well-Adapted Generic Medicines, International Intellectual Property Roundtable, Duke Law School (April 26-27, 2018) Colloquium: Voluntary Licenses to Accelerate Access to More Affordable Medicines, Program on Regulation, Therapeutics & Law, Harvard Medical School & Brigham & Women’s Hospital (April 18, 2018)

8

Overcoming Market Barriers to Novel, Well-Adapted Medical Technologies in Low- and Middle-Income Countries (CS Engagement in Unitaid), NUSL Health Law Roundtable (March 28, 2018) Global Summit on Intellectual Property & Access to Medicines, Marrakesh, Morocco (Jan. 15-17, 2018)

Plenary 1: Return to Marrakesh: Two Decades of TRIPS and Access to Medicines, TRIPS flexibilities: the importance of policy coherence, Moderator: Parallel Session II: Making compulsory licenses routine Roundtable I: TRIPS-minus: How can LDCs make effective use of the transition periods, How are LDCs making use of the transition periods? Roundtable III: Pro-health patent law reform in developing countries: possibilities and challenges, Two decades after TRIPS, why is patent law reform important?

2017 Policy papers/analyses, media:

Concept Note: Public Health in Bilateral Investment Treaties (Nov. 2017) Concept Note: Negotiating for better access to promote early market entry of medical products (Nov. 2017) Civil Society Guide on Status and Reform of the Harare Protocol (Nov. 2017) Status and Reform of the Harare Protocol and Related Matters (Nov. 2017) New Intellectual Property Strategy Enhancing Access to Medicines Announced in South Africa, NULR Online Forum (Oct. 24, 2017) https://nulronlineforum.wordpress.com/2017/10/24/new-intellectual-property-strategy-enhancing-access-to-medicines-announced-in-south-africa/ Brook K. Baker & Yousuf Vawda, Submission by University of KwaZulu Natal Affiliated Academics on the Draft Intellectual Property Policy of the Republic of South Africa Phase 1 2017 (Oct. 23, 2017) http://law.ukzn.ac.za/Libraries/2017-doc/Submission_by_UKZN_Academics_on_SA_Draft_IP_Policy_2017_-_23_October_2017.sflb.ashx Brook K. Baker & Katrina Geddes, Pharma industry ‘getting away with murder’ abroad thanks to Trump’s policies, STAT First Opinion (August 21, 2017) https://www.statnews.com/2017/08/21/pharma-trump-canada-patents/ Canada Blinks in Face of US/Pharma Pressure: Supreme Court Adopts Wink-Wink Patent Utility Rule, Health GAP Blog (July 3, 2017) http://www.healthgap.org/canada_blinks_in_face_of_us_pharma_pressure_supreme_court_adopts_wink_wink_patent_utility_rule Trump’s Draft Executive Order on Pharmaceutical Pricing: Dangerous Medicine for Consumers at Home and Abroad, Health GAP Blog (June 23, 2017) http://www.healthgap.org/trump_s_draft_executive_order_on_pharmaceutical_pricing_dangerous_medicine_for_consumers_at_home_and_abroad Trump’s Drug Pricing Executive Order is Likely to be an Unfettered Giveaway to Big Pharma: Insights from 2017 Special 301 Report, Health GAP Blog (June 21, 2017) http://www.healthgap.org/trump_s_drug_pricing_executive_order_is_likely_to_be_an_unfettered_giveaway_to_big_pharma_insights_from_2017_special_301_report Beyond the Obvious - Direct and Indirect Territorial Coverage of MPP/ViiV voluntary license dolutegravir, IP Watch (May 24, 2017) https://www.ip-watch.org/2017/05/24/beyond-obvious-direct-indirect-territorial-coverage-mppviiv-voluntary-license-dolutegravir/

9

Eli Lilly’s ISDS Patent Claim Against Canada Defeated, Guest Blog Madhyam.com (April 6, 2017) http://www.madhyam.org.in/eli-lillys-isds-patent-claim-against-canada-defeated/ Health GAP Analysis: Trump’s Trade Policy and Access to Medicines (February 21, 2017) Brook K. Baker & Matt Kavanagh, Preliminary Analysis of Impact of Trump’s Global Gag Rule on Global HIV/AIDS Programming, Including Safe Abortion Campaigning in Uganda (February 21, 2017) How activists transformed the TPP from a done-deal to dead-on-arrival, Health GAP blog (Feb. 1, 2017) http://www.healthgap.org/how_activists_transformed_the_tpp_from_a_done_deal_to_dead_on_arrival

2017 Presentations, Expert Consultations, and Trainings

Speaker, World AIDS Day Vigil: Where is Your Rage?, Harvard University (Dec. 1, 2017) Panelist, 1ST World Conference on Access to Medical Productions and International Laws for Trade and Health, in the Context of the 2030 Agenda for Sustainable Development, New Delhi, India (Nov. 21-23, 2017)

Plenary: TRIPS, UN High Level Panel Report and Benefit sharing for access to medical products; presentation – Public Health in Bilateral Investment Treaties Parallel Session: Achieving SDGs: Use of Information and Communication Technology Initiatives include in Trade Agreements; presentation – Negotiating for better access to promote early market entry of medical products

Expert Resource Person and Panelist, High Level Meeting on Promoting Policy Coherence on Health Technology Innovation and Access in the ARIPO Region, Lilongwe, Malawi (Nov. 1-3, 2017) Presentation: TRIPS and TRIPS Flexibilities

Discussion Group Leader: Days 2 and 3 Workshop on South African Draft Intellectual Property Policy – Phase I 2017, S.A. Dept. Trade & Industry, UNCTAD, UNDP, Pretoria, South Africa (Oct. 25-27, 2017) Strategy Retreat of NGO Delegation to Unitaid, Harare, Zimbabwe (Sept. 11-14, 2017) Training Section27 – Intellectual Property, Access to Medicines, and Economics of Pharmaceutical Industry and R&D, Johannesburg, South Africa (Sept. 8, 2017) Meeting with Director of HHS Office of Global Affairs on Global Access to Medicines and Health Technologies, Washington, D.C. (Aug. 10, 2017) IP Project Proposal Writing Group, Health Action International, Amsterdam, the Netherlands (June 13-15, 2017) UNITAID NGO pre-meetings, Board Retreat, and Executive Board Meeting, Geneva (June 4-8, 2017) UNITAID FAC and PSC Meetings, Geneva (April 26-27, 2017) Seminar, Pharma Wars: Intellectual Property, Trade, and Access to Medicines, Pharmaceutical Program Leadership Council, Boston University School of Public Health (April 20, 2017)

10

Moderator, Panel: Vaccine Development – Ethical Issues in Trials and Access, Between Complacency and Panic: Legal, Ethical and Policy Responses to Emerging Infectious Diseases, NUSL Center for Health Policy and Law and American Society of Law, Medicine & Ethics (April 14, 2017) Panel, Pharmaceutical IP Investments and ISDS – A Dangerous Brew: Eli Lilly v. Canada, Moving Toward a “Global Super Court”?: Examining and Reshaping Investor-State Arbitration, Loyola University Chicago School of Law (April 7, 2017) Panel, Faces of Global Health, Partners in Health Engage, Northeastern University (April 3, 2017) Panel, Global Health Challenges: 2017 and Beyond, 23rd Annual Global Development Conference, Harvard University (April 1, 2017)

Guest Lecture, Corporate Power Unbound: US Trade Agreements and Eli Lilly v. Canada, IP Law course, Boston University (February 21, 2017) Panelist, Teach-In on Immoral Pharmaceutical Price-Gouging & Access to Medicines Advocacy, Harvard (February 15, 2017) Global Health Justice: IP and Access to Medicines, Student Global AIDS Campaign National Conference, Harvard University (February 11, 2017)

2016 Policy papers/analyses, media:

Baker and Vawda Responses to Industry Arguments on DTI IP Consultative Framework (Nov. 8, 2016) Eliminating Provisions in Trade Agreements that Adversely Affect Affordability of Medicines, Conference paper for Suisse Credit and Capitol Forum: 2016 Washington Perspective: Drug Pricing Options –Executive Branch Options (Oct. 28, 2016) Yousuf Vawda, Brook K. Baker et al., Submission by Academics, Experts, Scholars and Pro-Access Advocates, South Africa Dept. of Trade & Industry, Intellectual Property Consultative Framework (Sept. 2016) http://ip-unit.org/wp-content/uploads/2016/09/Submission_IPUnit_IPFramework092016.pdf High-Level Submissions to UNITAID on Intellectual Property

TRIPS-Flexibility Law Reform Enabler Platform Defense against TRIPS-plus Platform Patent Opposition Facility/Consortium Compulsory Licensing Facility/Consortium Law Reform Platform for LDC Pharmaceutical Transition Period Addressing Patent Barriers to Therapeutic Combinations and Rational Fixed-Dose

Combinations Exploring Patent, Copyright and other IP Barriers in the Diagnostics Space

Brook K. Baker & Yousuf Vawda, “Why is it so difficult to understand whether medicines are under patent and when patent monopolies actually expire?” in PATENT BARRIERS TO MEDICINE ACCESS IN SOUTH AFRICA: A CASE FOR PATENT LAW REFORM, 13-14 (Fix the Patent Laws Campaign 2016) http://www.msfaccess.org/sites/default/files/ACCES_report_FTPL_ENG_2016.pdf Durban Reflections #1: The Treat of Big Pharma’s Monopolies Unbound, Health GAP Blog (July 21, 2016) http://www.healthgap.org/big_pharma_monopoly_unbound

11

Risky Medicine: Why FDI Investment in Indian Drugs Industry Could be a Bad Idea, THE WIRE INDIA (July 20, 2016) http://thewire.in/51899/domestic-global-risks-eased-direct-foreign-investments-indias-generics-industry/ U.S.'s Newest IP Gunship Diplomacy in Colombia - Same Threats with Dollars not Bullets (May 13, 2016) http://www.healthgap.org/u_s_s_newest_ip_gunship_diplomacy_in_colombia_same_threats_with_dollars_not_bullets Amicus Curiae Request and Submission (Accepted), Eli Lilly and Company v. The Government of Canada, UNCITRAL, ICSID Case No. UNCT/14/2 (with others) https://icsid.worldbank.org/ICSID/FrontServlet?requestType=CasesRH&actionVal=showDoc&docId=DC7516_En&caseId=C3544; https://icsid.worldbank.org/ICSID/FrontServlet?requestType=CasesRH&actionVal=showDoc&docId=DC7576_En&caseId=C3544; http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2791659 Submissions UN Secretary-General High Level Panel on Access to Medicines (Feb. 18, 2016)

Reform of Global and National IP Norms on Health Technologies, http://www.unsgaccessmeds.org/inbox/2016/2/26/z73kpodxk4jw96mhqe2tivq0sd1g3v Compulsory License Facility (co-author), http://www.unsgaccessmeds.org/inbox/2016/2/27/brook-baker

Least Development Country IP Law Reform Facility (co-author) http://www.unsgaccessmeds.org/inbox/2016/3/1/third-world-networkc

2016 Presentations, Expert Consultations, and Trainings

UNITAID NGO pre-meetings and Committee and Board Meetings, Geneva (Dec, 11-14, 2016) Moderator, Seizing the momentum: transforming the global R&D system for health, Open Society Foundation, Geneva (Nov. 8-9, 2016) Panel, Labor and Human Rights at Symposium: Global Governance and the Trans-Pacific Partnership, University of Buffalo (Nov. 5, 2016) Panel, Suisse Credit and Capitol Forum: 2016 Washington Perspective: Drug Pricing Options –Executive Branch Options (Oct. 28, 2016) UNITAID Committee Meetings, Geneva (Oct. 4-5, 2016) Break-out – Health GAP, Boston Student Health Activist Community Summit, Boston University Medical School (Sept. 24, 2016) International AIDS Conference, Durban, S. Africa (July 17-24, 2016)

Intervention, Affordable Treatment: 30 by 20 – What Will It Take? Treatment Activist Strategy Session (July 17) Intervention, Access, Equity & Rights: the crucial role of civil society and communities in the global AIDS response A Breakfast Dialogue with the United Nations Secretary General Ban Ki-moon (July 18) Intervention, Consultation on UNITAID Strategy 2017-21 (July 19) Intervention, Consultation: Medicines Patent Pool (July 19) Consultation, AmFAR Voluntary Licenses and Access to Medicines (July 19) Intervention, A Call to World Leaders to Enhance R&D and Access to Medicines: An Appeal to the UN High Level Panel (July 19) Panel, Meet Your [UNITAID] Representatives (July 20) Panels, Workshops, New R&D Model and Patent Oppositions (July 21)

12

UNITAID NGO pre-meetings and Committee and Board Meetings, Paris, France (June 18-23, 2016) Intellectual Property Strategy Consultation, Civil Society Engagement Strategy Consultation, and Policy and Strategy Committee Meeting, UNITAID, Geneva (May 25-26, 2016) Moderator, Panel: Global Health, Conference on Individual Choice, Collective Destiny: The Future of Public Health, NUSL (April 15, 2016) Panelist: The Global Response to the Zika Pandemic, Northeastern University (April 6, 2016) UNITAID NGO pre-meetings and Board Meeting, Geneva, Switzerland (March 15-17, 2016) Hearing and Global Dialogue, United Nations Secretary-General’s High-Level Panel on Access to Medicines, London, UK (March 9-10, 2016) Colloquium: Corporate Power Unbound: Investor-State Arbitration of IP Monopolies on Medicines – Eli Lilly v. Canada and the Trans-Pacific Partnership Agreement, Boston University (Feb. 25, 2016) Technical Working Group Meeting of the Equitable Access Initiative, Global Fund to Fight, AIDS, Tuberculosis and Malaria and partners, Geneva (Feb. 22, 2016) Panel: The Trans Pacific Partnership Agreement – The Looming Threat to Health, Environment, and Labor, Northeastern U. School of Law (Feb. 16, 2016)

2015 Policy papers/analyses, media:

Written Submission from Health GAP – “Trading Views: Real Debates on Key Issues in TPP” hearing on access to medicines – U.S. House of Representatives Ways and Means Committee Hearing, Dec. 8, 2015, http://infojustice.org/archives/35504 & http://democrats.waysandmeans.house.gov/issue/trading-views-real-debates-key-issues-tpp WBAI Health Action: Annual World AIDS Day Special (Nov. 30, 2015. 1:15 p.m.) LDCs be damned: USTR and Big Pharma seeks to eviscerate Least Developed Countries' insulation from pharmaceutical monopolies (Oct. 12, 2015) http://infojustice.org/archives/35147 Brook K. Baker, Will the U.S. create barriers to LDCs’ future access to medicines, PIPIJ InfoJustice (Sept. 6, 2015) http://infojustice.org/archives/34956 Moses Mulumba & Prof. Brook K. Baker, CSO Perspectives on the “Developing Innovation and Intellectual Property Policy and Strategy for Uganda: Road Map – Draft National Intellectual Property Policy” (Aug. 13, 2015) Removal of “new forms” patent protection from the most recent TPP draft (Aug. 5, 2015) http://infojustice.org/archives/34822 Trans-Pacific Partnership Transparency for the Big Pharma Wrecking Crew, Health GAP Blog (June 11, 2015) http://www.healthgap.org/trans_pacific_partnership_transparency_for_the_big_pharma_wrecking_crew Special 301 Report annual swat at India's IP policies, 30/25 Express Pharma 30-31 (2015) http://issuu.com/indianexpressgroup/docs/ep-20150615pages/29?e=0

13

Gilead Anti-Diversion Program for Hep C Medicines Throws Patient Rights under the IP Bus (March 23, 2015) http://www.healthgap.org/gilead_anti_diversion_program_for_hep_c_medicines_throws_patient_rights_under_the_ip_bus LDC Members Entitlement to and Need for Further Extension of Their Pharmaceutical Transition Period (Feb. 25, 2015) http://infojustice.org/archives/33969 Srividhya Ragavan & Brook K. Baker, India’s Draft National IPR Policy: Need to Stress Innovation and Creativity While Balancing IP and Access To Essential Public Goods (Feb. 2, 2015) https://drive.google.com/file/d/0B8M-eytmCbwXR1BSTjQ2VnFKMXFJRmJ4WEphamNfMDd0MVZZ/view Srividhya Ragavan, Brook Baker & Sean Flynn, Comments on India’s National IPR Policy (Oct. 30. 2015) available at: http://patentlyo.com/patent/2015/02/national-intellectual-property.html US IP and Investment Pressure Continues: Will a New US-led IP Empire in India Put Access to Medicines at Risk?, Express Pharma (Jan. 30, 2015) No Track for Fast Track: President's State of the Union address call for trade promotion authority is a call to strengthen pharmaceutical monopolies (Jan. 23, 2015) http://www.healthgap.org/no_track_for_fast_track The Cynical Connectedness of Gilead's Hepatitis C Pricing and Anti-Diversion Policies, TheBodyPro (Jan. 16, 2015) http://www.thebodypro.com/content/75407/the-cynical-connectedness-of-gileads-hepatitis-c-p.html?ap=1100

2015 Presentations, Expert Consultations, and Trainings

Panel: A Universal Movement for Access: Crossing Barriers, 4th Global Congress on Intellectual Property & the Public Interest, New Delhi, India Dec. 15-17 (2015). UNDP Expert Planning Meeting re UN S-G HLP, New York City (Nov. 24, 2015) Guest Lecture: Human Rights, IP, and the Campaign for Access to Medicines, Case Studies in Global Health: Biosocial Perspectives, Harvard College (Nov. 17, 2015) UNITAID Civil Society Consultation, New York City (Nov. 13, 2015) UNITAID NGO pre-meetings and Board Meeting, Geneva, Switzerland (Nov. 1-5, 2015) Hep C Panel: Lessons Learning from HCV – Ensuring Access to Future Drugs, Universities Allied for Essential Medicines, North America Fall Conference, Boston University (Oct. 17, 2015) Panel, Invisible Barriers: A panel on the obstacles university medical research faces on its path to meeting the needs of patients in the US and abroad, NUSL (Oct. 1, 2015) Global Hepatitis Summit (by invitation only), Glasgow (Sept. 3-4. 2015) Equitable Access Initiative: Analytical Advisory Meeting, Geneva (July 28, 2015) UNITAID NGO pre-meetings and Board Meeting, Rio de Janeiro, Brazil (May 31-June 4, 2015) UNAIDS IP Think Tank Meeting, Geneva (May 27, 2015)

14

Briefing on Voluntary Licenses, Doctors without Borders Access to Medicine Retreat, Geneva (May 26, 2015) Intersectoral consultation on Patent Law Reform in Indonesia and Technical Briefing Ministry of Law drafting team, Jakarta, Indonesia (May 12-13, 2015) Commentator, NUSL Colloquium: Amy Kapczynski, the Right to Medicines in an Age of Neoliberalism (May 6, 2015) UNITAID FAC and PSC Committee Meetings and Board Retreat, Geneva (April 22-23, 2015) Panel, Price and Prejudice: The Global Fund and Access to Essential Medicines, Workshop: Influencing Global Fund Policies and Practices to Advance Human Rights, Barcelona, Spain (April 13, 2015 – by Skype) Discussant, OSF Public Health Program Portfolio Review: Whose rights matter? When patents stand in the way of access to medicines (March 4, 2015) In-Country Consultation, Study on the Implications of the New Status of Kenya as a Middle-Income Country on Sustainability of the National HIV and AIDS Response: Intellectual Property Component, Nairobi, Kenya (Feb. 24-27, 2015) Technical Working Group Meeting of the Equitable Access Initiative, Global Fund to Fight, AIDS, Tuberculosis and Malaria and partners, Geneva (Feb. 23, 2015) Presentation, Pharma Wars: IP, trade agreements and access to medicines, National Conference Student Global AIDS Campaign, Harvard (Feb. 21, 2015)

2014 Policy papers/analyses, media:

Brook K. Baker and Yousuf Vawda, Op-Ed: Academics for TAC, Daily Maverick (Nov. 14, 2014) http://www.dailymaverick.co.za/article/2014-11-14-op-ed-academics-for-tac/#.VGWLW_SUfd4 Srividhya Ragavan, Sean Flynn, Brook K. Baker, and Raj S. Dave, Submission to the USTR India Out of Cycle Review (Oct. 31, 2014) http://www.regulations.gov/#!documentDetail;D=USTR-2014-0020-0013 International Collaboration in Training on Intellectual Property and Access to Medicines: The Birth of the S. Africa Fix the Patent Laws Campaign, Conference Paper – Workshop on “Constitutional Rights, Judicial Independence and the Transition to Democracy: Twenty Years of South African Constitutionalism,” New York Law School (October 23, 2014) http://www.nylslawreview.com/wp-content/uploads/sites/16/2014/10/Baker.pdf The Dangers of the Indian Government’s Flirtation with U.S. Pharma and the Risks for India’s Coherent, Pro-Public Health IP Policy, Equilibri-GESPAM (Oct. 5, 2014) http://www.peah.it/2014/10/the-dangers-of-the-indian-governments-flirtation-with-u-s-pharma-and-the-risks-for-indias-coherent-pro-public-health-ip-policy/ and http://infojustice.org/archives/33354 ‘PM Modi must firmly rebuff US pressure to dilute India’s robust patent law’, The Hindu Business Line (Sept. 19, 2014) http://www.thehindubusinessline.com/features/pulse/pm-modi-must-firmly-rebuff-us-pressure-to-dilute-indias-robust-patent-law/article6427225.ece Gilead’s Hepatitis C Medicines License – Troubling Territorial Exclusions, Illusory Exceptions, and Tiered Pricing Policy Fracture Global Access (September 16, 2014) http://infojustice.org/archives/33270

15

Gilead’s Proposed Hepatitis C Medicines License: How Badly Will It Miss the Target (September 12, 2014) http://infojustice.org/archives/33253 The inclusion of investor-to-state dispute settlement (ISDS) in Transatlantic Trade and Investment Partnership (TTIP) would undermine public health (co-author, joint response to the public consultation on investment protection and ISDS in TTIP, 11 July 2014) MSF victorious in overcoming registration barrier to important 2d line treatment of DR-TB, but patent barrier may last a little bit longer (July 2, 2014) http://infojustice.org/archives/32931 Released Text of GF Equitable Access Initiative Still Problematic (May 16, 2014) http://infojustice.org/archives/32744 Critical Analysis of Global Fund’s Proposed Equitable Access Initiative: GF-B31-ER8 (May 16, 2014) http://infojustice.org/wp-content/uploads/2014/05/Critical-Analysis-of-Global-Fund’s-Proposed-Equitable-Access-Initiative-final.pdf Civil Society to the Global Fund: Abandon the Tiered-Pricing Initiative (May 13, 2014) http://infojustice.org/archives/32727 Analysis of ViiV/NPP Dolutegravir Licenses – Pluses and Minuses (April 23, 2014) http://infojustice.org/archives/32633 Realizing the Right to Health by Ensuring Access to Medicines, International Workshop on the Fundamental Right to Health and Access to Affordable Medicines, Workshop Paper (April 2, 2014) Industry-Led Tiered-Pricing or Country-Led, Real Equitable Access – The Global Fund’s Task Force Proposal Gets Worse Instead of Better (March 28, 2014) http://infojustice.org/archives/32565 Ragavan-Flynn-Baker Post Hearing Comment 2014 Special 301 Review (March 7, 2014) Brook K. Baker & Matthew Kavanagh, Health GAP 2014 Special 301 Watch List Submission (March 7, 2014) http://infojustice.org/wp-content/uploads/2014/03/Health-GAP-2014-Special-301-Watch-List-Submission-Health-GAP-final.pdf Post-Hearing Comments, United States International Trade Commission: Investigation No. 332-543 – Trade, Investment, and Industrial Policies in India: Effects on the U.S. Economy (with Profs. Srividhya Ragavan and Sean Flynn), February 25, 2014 US's "new" proposed TPP IP Chapter still requires patents on medicinal forms with "distinguishing features", February 7, 2014 http://infojustice.org/archives/32152 Submission to United States International Trade Commission: Investigation No. 332-543 – Trade, Investment, and Industrial Policies in India: Effects on the U.S. Economy (with Profs. Srividhya Ragavan and Sean Flynn), February 7, 2014 Note on Reported Gilead License for Hepatitis C Medicines, February 6, 2014 http://infojustice.org/archives/32126 PhRMA Bares its Fangs: South Africa Patent Law Reform and Access to Medicines at Risk Again (Jan. 18, 2014) http://infojustice.org/archives/31986

2014 Presentations, Expert Consultations, and Trainings

16

Civil Society pre-meetings and UNITAID board meeting, Geneva, Switzerland, December 8-13, 2014 Panel: Ebola: Legal and Policy Issues, Northeastern University Health Policy and Law Roundtable, November 18, 2014 Presentation: South Africa Fix the Patent Act Campaign, Workshop on “Constitutional Rights, Judicial Independence and the Transition to Democracy: Twenty Years of South African Constitutionalism” New York Law School, Nov. 13 - 16, 2014 UNITAID committee meetings, Geneva, Switzerland, November 6-7, 2014 Commentator, Workshop: Differential Pricing, Washington College School of Law, American University, Washington DC, October 31, 2014 Workshop: Patent Regimes and the Right to Science and Culture, Yale University, October 29, 2014 Speech – Connecting the Global and Local: Single Payer and Ebola – Structural Elements to Local and Global Health Needs, Global Day of Action – Boston Article 25 Coalition, Boston Commons (Oct. 26, 2014) International Perspectives on the Fix the Patent Law Campaign, Treatment Action Campaign Intellectual Property (IP) and Access to Medicines Summit, Pretoria, S. Africa (by Skype, October 20, 2014) UNITAID board meeting, Geneva, Switzerland, June 12-13, 2014 Civil Society pre-meetings and UNITAID committee meetings, Geneva, Switzerland, May 3-6, 2014 Panel, Reforming Brazilian Pharmaceutical Patent Policy: Lessons from the Past and the Road for the Future, Harvard Law School (April 23, 2014)

UNITAID HIV Market Forum, Geneva, Switzerland, April 7-8, 2014 Briefing for Brazilian Parliament, Health and Access to Medicines as a Human Right and Challenges and potential solutions in IP affecting access and health: why the Brazilian patent law reform matters, Brasilia (3 April 2014) Realizing the right to health in the field of access to medicines, Panel: Policy options for overcoming barriers for Middle Income Countries, International Workshop on the Fundamental Right to Health and Access to Affordable Medicines, Rio de Janeiro, Brazil (1-2 April 2014) Chair, Breakout Session: International and Transnational Perspectives, Legal Scholarship 4.0, Northeastern U. School of Law (March 14, 2014) Trans Pacific Partnership – US IP Extremism: Threats to Medicines and Other Essential Goods, Northeastern U. School of Law (Feb. 6, 2014) Commentary, Public Screening of Fire in the Blood, Emerson Theater, Boston MA (Jan. 31, 2014)

2013 Policy papers/analyses, media:

Analysis of Territorial Access Issues in the MPP/BMS Atazanavir License (Dec. 16, 2013) http://infojustice.org/wp-content/uploads/2013/12/baker12162013.pdf

17

Differential Treatment and Developing Country Transition Periods in the IP Chapter of the TPP (Dec. 5, 2013) http://infojustice.org/archives/31646 US’s Proposed TPP Transition Period for Middle-Income Parties is Fools Gold (Dec. 2, 2013) http://infojustice.org/archives/31540 Investor-State Dispute Resolution under Trade Agreements and Affordability of Medical Care (Nov. 25, 2013) http://infojustice.org/archives/31395 What Patent Law Reform in Brazil and South Africa Can Mean, Pharmalot (Nov. 12, 2013) http://www.pharmalive.com/the-op-ed-what-patent-reform-in-brazil-and-south-africa-can-mean Tobias Schonwetter, Yousuf Vawda, Brook K. Baker, et al., Comments: Draft National Policy on Intellectual Property (IP) of South Africa (Oct. 17, 2013) http://ip-unit.org/wp-content/uploads/2013/10/IP-Policy-Academics-Submission_final171013.pdf Treatment Action Campaign, Médecins Sans Frontières, Section27, Joint Submission on Draft National Intellectual Property Policy of South Africa (2013) (policy advising and partial editing) http://ip-unit.org/wp-content/uploads/2013/10/IP-Policy-Academics-Submission_final171013.pdf US Pharma v. India Patent Act: Myths Abound (Oct. 14, 2013) http://infojustice.org/archives/30947 What the Doctor Ordered, Hindu Business Line (Oct. 11, 2013) http://www.thehindubusinessline.com/opinion/what-the-doctor-ordered/article5225817.ece With One Exception Current Trade Agreements Do Not Appear to Include Biologic Medicines in their Data Protection/Data Exclusivity Provisions – Implications for TPP Negotiation (Aug. 13, 2013) http://infojustice.org/wp-content/uploads/2013/08/baker082013.pdf South African IP policy approved by Cabinet for public consultation (Aug. 12, 2013) http://www.fixthepatentlaws.org/?p=646 Civil Society Statement in Support of Brazilian Patent Law Reform to Increase Access to Medicines for All (July 15, 2013) http://infojustice.org/civil-society-statement-brazil-july2013 Open Letter from Global Academics and Experts in Support of Proposal to Amend Brazil’s Patent Law to Take Advantage of TRIPS-compliant flexibilities (July 8, 2013) http://infojustice.org/support-brazil Congressional Letter Challenging Indian IP Policy Falsely Condemns Protectionism While Trouble-Shooting for Big Pharma, Infojustice (June 19, 2013) http://infojustice.org/archives/29967 Radio Interview – Generic Drug War: Global South vs. Big Pharma, WBAI Asia Pacific Forum (June 18, 2013) http://www.asiapacificforum.org/show-detail.php?show_id=309#876 LDC and Civil Society Coalition Win a Partial Victory in Extending LDCs’ Freedom from Oppressive Intellectual Property Rights (June 11, 2013) http://healthgap.org/blog/2013/6/11/ldc-and-civil-society-coalition-win-a-partial-victory-in-extending-ldcs-freedom-from-oppressive-intellectual-property-rights Bad faith negotiation tactics in LDC extension request, TWN Info Service on WTO and Trade Issues (May 28, 2013) http://www.twn.my/title2/wto.info/2013/twninfo130509.htm

18

The Interaction of the Proposed LDC Extension Request and the 2016 Pharmaceutical Extension (May 13, 2013) http://infojustice.org/archives/29548 Investors’ IP Rights Unbound: The Danger of Investment Clauses to Access to Medicines, GESPAM (April 24, 2013) http://www.peah.it/2013/04/investors-ip-rights-unbound-the-danger-of-investment-clauses-to-access-to-medicines/ A patent victory under threat, The Hindu Business Line (April 13, 2013) http://www.thehindubusinessline.com/opinion/a-patent-victory-under-threat/article4610739.ece Debunking Pharma’s Cant Against the Novartis Judgment: Myth and Fact (April 2, 2013) http://www.twnside.org.sg/title2/intellectual_property/info.service/2013/ipr.info.130403.htm Analysis: India’s Supreme Court Upholds Strict Patent Standards and Patients’ Right to Access to Affordable Medicines; Court dismisses unmeritorious court challenge by drug giant Novartis (April 1, 2013) http://www.actupbasel.org/actupbasel/?Analysis-India-s-Supreme-Court Debunking IP-for-Development: Africa Needs IP Space Not IP Shackles (Conference Paper - Second African International Economic Law Network Conference 2013) Detailed Analysis of Medicines Patent Pool-ViiV Pediatric ARV License and Memorandum of Understanding, 3:10 UNITAID – The Market Share 2 (12 March 2013) http://www.unitaid.eu/images/themarketshare/UNITAID_TheMarketShare_12March2013.pdf full version available at http://infojustice.org/archives/28771

The Battle to End AIDS: Show Me The Money!, 5(4) Achieve 14-17 (2013) http://img.thebody.com/cria/2012/achieve_winter2012.pdf#page=14

2013 Presentations, Expert Consultations, and Trainings

Civil Society Consultation, CS Pre-Meeting and UNITAID Executive Board Meeting, Geneva, Switzerland (Dec. 9-13, 2013) Speaker, World AIDS Day Rally, Harvard University (Dec. 2, 2013) Panel, World AIDS Day – HIV/AIDS Education and Prevention, Northeastern University (Dec. 2, 2013) UNITAID Board Retreat and FAC and PSC Meetings (Nov. 13-15, 2013) Treatment as Prevention for HIV – Focusing on Intellectual Property and Market Dynamics, Northeastern University Global Health Fridays Seminar Series (Oct. 18, 2013) Panel - Harnessing Interdisciplinary Perspectives to Inform Effective Health Policy and Law in HIV/AIDS Response, Northeastern University Health Roundtable (Sept. 25, 2013) Health Policy Round Table, Report-Back: Global HIV Policy Grand Rounds – the Benefits of Interdisciplinary Collaboration and Perspectives, NU Health Policy and Law (September, 2013) Panel – Critical Perspectives on Gender, Movements, and Identity, Conference: Movements for Sexual and Reproductive Health and Rights: Critical Perspectives, Northeastern U. School of Law (September 12-13, 2013) Presentation: The Current IP Policy Landscape & the Commission’s Recommendations on IP and Treatment Access; and Panel: Discussion of Human Rights Options – Expert Meeting on IP

19

recommendations of the Global Commission on HIV and the Law, UNDP New York City (Sept. 4-5, 2013) U.S. Africa Solidarity in the 21st Century: A Strategic Consultation, U.S. Africa Network, Kalamazoo, Michigan (June 21-24, 2013) Consultation on Access to HIV Medicines in Middle-Income Countries, Chair – Working Group on Voluntary Licenses, UNAIDS, UNITAID, WHO, Health Ministry of Brazil, Brasilia (June 10-12, 2013) Civil Society Pre-Meeting and UNITAID Executive Board Meeting, Geneva, Switzerland (June 2-8, 2013) Pharma Wars and U.S. Funding & Policy Incoherence in Global AIDS, Harvard Medical School (May 31, 2013) Pharma Wars and U.S. Funding & Policy Incoherence in Global AIDS, Global Health course, U. Mass. Boston (May 1, 2013) IP Fundamentalism or Pluralism: Purposes and Trade-offs, a Case Study in India, Intellectual Property Society, NULS (April 29, 2013) Expert Meeting, Human Rights Strategies on Intellectual Property, Yale University (April 26, 2013) Expert Group, Panel: UAEM Boston-wide Forum on Global Access Licensing of Biomedically Relevant Technologies, Harvard Medical School (April 25, 2013) Corporate Power Unbound: Investor State Enforcement of IP Monopolies, Faculty Scholarship Luncheon, Northeastern U. School of Law (April 10, 2013) Panel, Pharma Wars: Intellectual Property, Trade and Access to Medicines, New England Law School, International Law Society's Human Rights Awareness Day (March 28, 2013) Informal UNITAID Brainstorming Meeting on IP Issues, Geneva, Switzerland (March 21, 2013) Presentation, De-bunking IP-for-development claims: Africa needs IP-space not IP-shackles and Chair two panels, Intellectual Property and Competition at Trade Governance: Integrating Africa into the World Economy through International Economic Law, Second African International Economic Law Network Conference, Witwatersrand Law School, Johannesburg, South Africa (March 7-8, 2013) Presentation, Global Health Activism, Progressive Health Activists, Jamaica Plain, MA (Feb. 7, 2013) Career Paths in Global Health: An Interprofessional Panel Discussion, Northeastern University (Jan. 24, 2013)

2012 Policy papers/analyses, Media:

J&J Patent Move is Inadequate, OpEd Pharmalot (Nov. 30, 2012) http://www.pharmalot.com/2012/11/the-op-ed-jj-patent-move-is-inadequate/#comments Intellectual Property Policy Incoherence at the African Union Threatens Access to Medicines - Proposed Pan-African IP Organization a Terrible Idea (Sept. 26, 2012) http://www.fixthepatentlaws.org/?p=438

20

Leaked TPP Investment Chapter Presents a Grave Threat to Access to Medicines (Sept. 11, 2012) http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2189125 Proposed HIV Medicines Alliance - Promise or Peril, 2 THE MARKET SHARE 4 (July 17, 2012) http://www.unitaid.eu/images/themarketshare/UNITAID_The-Market-Share_17%20July%202012.pdf Treating People Right Means Taking the IP Yoke off Our Back: A Ten-Point Plan to Ensure Access to New and Improved AIDS Medicines (July 13, 2012) http://treatpeopleright.org/tpr/?Treating-People-Right-Means-Taking USPTO Official Misleads Congress on Permissible Scope of Compulsory Licenses to Increase Access to Medicines (June 28, 2012) http://infojustice.org/archives/26461 PhRMA's Sham Charm Campaign on TPP Access Window (May 7, 2012) http://donttradeourlivesaway.wordpress.com/2012/05/08/phrmas-sham-charm-campaign-on-tpp-access-window/ Bayer Appeals Indian Compulsory License for Nexar (May 6, 2012) http://infojustice.org/archives/20207 Debating the World Bank Report on Fiscal Restraints: A Return to the 90’s (March 28, 2012) http://www.globalhealthcheck.org/?p=749 Interview, India ruling on cancer drug to be challenged, Al Jazerra News Doha (March 14, 2012) Drugs and Duplicity, 29:8 Frontline 28-29 (May 4, 2012) http://www.frontlineonnet.com/fl2908/stories/20120504290802800.htm Why global health activists are fired up about Novartis, Science Speaks: HIV & TB NEWS (Feb. 27, 2012) http://sciencespeaksblog.org/2012/02/27/why-global-health-activists-are-fired-up-about-novartis/ Joao Carpinha & Brook K. Baker, The spice trade of antiquity and contemporary medicine trade appear to share much in common (Feb. 16, 2012) http://www.carapinha.com/733 Science Soars – PEPFAR Budget Plummets (Feb. 14, 2012) http://lists.critpath.org/pipermail/healthgap/2012-February/003349.html Novartis, Big Pharma, and their US and EU Surrogates Throw a Triple Punch at Indian Generics (Feb. 10, 2012) http://actupbasel.org/actupbasel/?Novartis-Big-Pharma-and-their-US Contributions, Amrita Pairwala & Rebecca Goulding, PATENT POOLS: ASSESSING THEIR VALUE-ADDED FOR GLOBAL HEALTH INNOVATION AND ACCESS, Results for Development Institute (2012) http://healthresearchpolicy.org/assessments/patent-pools-assessing-their-value-added-global-health-innovation-and-access Editing, UNDP, DISCUSSION PAPER – ANTI-COUNTERFEITING LAWS AND PUBLIC HEALTH: WHAT TO LOOK OUT FOR (2012) http://www.undp.org/content/dam/undp/library/hivaids/English/UNDP%20Discussion%20Paper%20-%20(revised).pdf

2012 Presentations, Expert Consultations, and Trainings

Presentation, Turning the Tide on AIDS: Addressing Pharma’s Offensive and Funding/Efficiency

21

Constraints, BC GlobeMed, Dec. 5, 2012 Panel, HIV and Community Health: A Global Perspective, World AIDS Week at Northeastern (Dec. 3, 2012) Panel, NATCO: Is India’s first compulsory patent license the dawning of a new era of access to medicine in emerging markets?, ASIL International Economic Law Interest Group Biennial Conference, George Washington School of Law, Washington, DC, Nov. 30, 2012 Presentation, Key Principles and Considerations That Should Guide Voluntary Licenses, TAC/Section27 Meeting on Terms and conditions for Voluntary Licenses in the Field of HIV, Nov. 9-10, 2012, Johannesburg, S. Africa Co-Instructor, Intellectual Property and Access to Medicine Two-Week Intensive Mini-Course, University of Kwazulu-Natal, Durban, S. Africa, Nov. 5-16, 2012 HIV/AIDS Policy Grand Rounds: Interdisciplinary Perspectives and Questions - Treatment for/plus/as Prevention, Northeastern University, Sept. 11, 2012 Presentation, The Dangers of the TPP Investment Clause on Access to Medicines, Stakeholders Meeting, Trans-Pacific Partnership Agreement Negotiations, Leesburg, Virginia, Sept. 9, 2012 Drafting Consultation, Revised Uganda Industrial Property Bill, Serena Lake Victoria Resort, Uganda, August 20-22, 2012 Presentation, Pharma Wars, Funding Crises, and Truth about Efficiencies, Partners in Health, Boston, MA, August 7, 2012 XIX International AIDS Conference, Washington D.C., July 22-27, 2012

• Satellite Session – Moderator, Proposals for a Global Innovation System that Responds to Patients Needs and Ensures both Innovation and Access

• Symposia Session - Panel, Intellectual Property Rights, Access and Innovation: Overcoming Barriers to Accessing Second Line ARV Drugs, (July 24, 2012)

• Networking Zone – Panel, The HIV medicine pipeline in developing countries: Threats and Challenges (July 25, 2012)

Global Health Evidence Summit: Community and Formal Health System Support for Enhanced Community Health Worker Performance, USAID Washington D.C. (May 31-June 1, 2012) Panel, Trade in India, New York City Bar Association - International Trade Committee (May 23, 2012) NATCO: Is India’s first compulsory patent license the dawning of a new era of access to medicines and R&D in emerging markets, NU Faculty Interdisciplinary Roundtable on Law and Business, April 24, 2012 Panel, Placing Local HIV/AIDS in a National and Global Context, NU Face AIDS, April 5, 2012

Guest Lecture, Resource Needs and Funding for Health Systems, Global Health Seminar, U. Mass. Boston, April 4, 2012 Multiple Presentations, Consultative Meeting on Draft Industrial Property Bill 2009 and Related Legislation, UNDP and Uganda Registration Services Bureau, Entebbe, Uganda, 29-30 March 2012 Presentation, Emerging issues in global access to medicines and opportunities for engagement,

22

Division of Medical Sciences Policy Group, Global Health Initiative, Universities Allied for Essential Medicines, Harvard Medical School, March 14, 2012 Moderator, Panel – Global Health and Human Rights Research Projects, The Program on Human Rights and the Global Economy, Northeastern U. School of Law, February 16, 2012 The Role of Patents in Access to Medicines, American Medical Student Association Pharmaceutical Policy Leadership in Medicine Institute, Reston, VA, January 7, 2012

2011 Policy papers/analyses, Media:

How We Got the Commitment to 6 Million (Dec. 10, 2011) http://www.eatg.org/eatg/Global-HIV-News/Access-to-treatment/How-we-got-the-commitment-to-6-million Interview, Bob Moon: American Public Radio Marketplace (Dec. 1, 2011) http://www.marketplace.org/topics/world/world-aids-day-generics-lacking-0 Health GAP Policy Analysis: U.S. Patent and Data Protection Proposals in Trans-Pacific Partnership Negotiations – A Grave Threat to Access-to-Medicines (Nov. 28, 2011) http://www.healthgap.org/documents/HealthGAPPolicyAnalysis_TPP.pdf Novartis: Keeping Its Head in the Sand re the Impact of Its Challenge to the India Patent Act (Nov. 11, 2011) http://actupbasel.org/actupbasel/?Novartis-Keeping-Its-Head-in-the US Trade-Enhancing Access to Medicines (Access Window) in its proposed TPP IP text is a sham (Oct. 25, 2011) http://infojustice.org/resource-library/trans-pacific-partnership/us-trade-enhancing-access-to-medicines-access-window-in-its-proposed-tpp-ip-text-is-a-sham US Doha flexibilities in its proposed TPP IP text are not nearly good enough (Oct. 23, 2011) http://infojustice.org/resource-library/trans-pacific-partnership/us-doha-flexibilities-in-its-proposed-tpp-ip-text-are-not-nearly-good-enough Analysis of Civil Society Petition to the Medicines Patent Pool (Oct. 13, 2011) http://lists.keionline.org/pipermail/ip-health_lists.keionline.org/2011-October/001411.html Novartis’s Second Bite at the Section 3(d) Apple (Sept. 6, 2011) http://lists.keionline.org/pipermail/ip-health_lists.keionline.org/2011-September/001261.html Interview, Ed Silverman: Novartis, A Gleevec Patent & India: Baker Explains, Pharmalot (Sept. 7, 2011) http://www.pharmalot.com/2011/09/novartis-a-gleevec-patent-india-baker-explains/ Biased IP Technical Assistance, Judicial Independence, and Recusals – Novartis’s attack on India Patent Act and Beyond (Sept. 11, 2011) http://donttradeourlivesaway.wordpress.com/2011/09/12/biased-ip-technical-assistance-judicial-independence-and-recusals-novartiss-attack-on-india-patent-act-and-beyond/ Public Citizen & Health GAP, Briefing Memo: Vietnam and the Trans-Pacific Partnership Agreement (2011) http://www.citizen.org/documents/Vietnam-and-the-Trans-Pacific-Partnership-Agreement.pdf and Chart: Comparative Analysis of the U.S. Intellectual Property Proposal and Vietnamese Law (2011) http://www.citizen.org/documents/tppa-access-chart.pdf Public Citizen, Health GAP, TWN, & I-MAK, Briefing Memo: Risks of the Trans-Pacific Free Trade Agreement for Access to Medicines - Analysis of the Leaked U.S. Paper on Eliminating Pre-Grant Opposition (2011) http://www.citizen.org/documents/analysis-of-leaked-US-paper-on-eliminating-pregrant-opposition.pdf

23

Corporate Self-Interest and Strategic Choices: Gilead Licenses to the Medicines Patent Pool, IP-Watch (July 21, 2011) http://www.ip-watch.org/weblog/2011/07/21/corporate-self-interest-and-strategic-choices-gilead-licenses-to-medicines-patent-pool/ Kevin Outterson & Brook Baker, Stand firm on Pharmac – law expert, PHARMACY TODAY (June 3, 2011) http://www.pharmacy-today.co.nz/blog?objId=54b5b550-67da-4dfd-94d6-fe70371c8886 Mission Crash: The Intolerable Policy Incoherence in US AIDS Policy, Global and Domestic (May 14, 2011) http://www.africafocus.org/docs11/hiv1105.php

Contributions, Discussion Paper: The Doha Declaration Ten Years on and Its Impact on Access to Medicines and the Right to Health (UNDP 2011) http://www.beta.undp.org/content/dam/undp/library/hivaids/Discussion_Paper_Doha_Declaration_Public_Health.pdf Contributions, CARE AND SUPPORT: THE FORGOTTEN PILLAR OF THE HIV RESPONSE (UK Consortium on AIDS and Int’l Development 2011) http://www.aidsconsortium.org.uk/Care&Support/Publications/Care&SupportAdvocacyDoc2011.pdf Contributions, Mark Weisbrot & Rebecca Ray, Scorecard on Development 1960-2010: Closing the Gap (Center for Economic Policy Research April 2011) http://www.cepr.net/documents/publications/scorecard-2011-04.pdf

2011 Presentations, Expert Consultations, and Trainings

Second Global Forum on Human Resources for Health, January 25-29, 2011, Bangkok, Thailand • Presentation of CS Platform, Side Session Health Workforce Advocacy Initiative, January 25 • Moderator, Global Health Workforce Alliance Members Post-Forum Session, January 30 HEARD, Slums and HIV Meeting, February 16, 2011, UKZN, Westville, S. Africa OSF Public Health Program seminar, A Taste of their own Medicine! Campaigning on Intellectual Property Rights and Access to Essential Medicines, March 28-30, 2011 Livingstone, Zambia Presentation: African Health Workforce & Panel: Targeting Specific Drivers to Fast Track Rebuilding the Healthcare Sector, Leaders in Healthcare Conference, Johannesburg, South Africa, May 9, 2011 UNDP-SADC Workshop on Intellectual Property Enforcement and Access to Essential Medicines, Pretoria, South Africa, June 22-23, 2011 • Panelist, Potential impact of Partnership Agreements (EPAs) negotiations on public health • Moderator, Proliferation of National Anti-Counterfeiting Legislation: The Experience of EAC

Countries • Co-facilitator, Mitigating the negative impacts of anti-counterfeit legislation and developing a

public health agenda for ensuring safe and efficacious medicines of good quality

Co-Instructor, Intellectual Property and Access to Medicine Two-Week Intensive, University of Kwazulu-Natal, Durban, S. Africa, June 27-July 8, 2011 Global Congress on Public Interest Intellectual Property Law, American University, August 25-27, 2011 • Panel, Limitations and Exceptions for Special Subjects and Objects • Co-Chair, Access to Medicines I: FTAs and Enforcement • Co-Chair, Access to Medicines II: Patent Pool and Licenses

24

Panelist, UNDP/Government of Brazil Side Event on “Promoting Access to Essential Drugs at Home and in the Global South” at the UN High Level Meeting on Non-Communicable Diseases, September 20, 2011, New York City, New York Commentator, Reflections and Next Steps: Opportunities for Collaboration, Questions and Research Topics, IP/Innovation Connection, Northeastern University, September 27, 2011 Presentation, The Role of the Medicines Patent Pool in access to HIV Medicines – What Can the Pool Offer, What to do Where the Pool Cannot Deliver, UNITAID 3rd Consultative Forum, October 4-5, 2011, Geneva, Switzerland Panelist, Conflicting Trajectories – The Promise of Treatment as Prevention, NUSL World AIDS Day Panel 2012: The Beginning of the End of AIDS?, Northeastern University Dec. 1, 2011 Discussant, Water and HIV, NUSL Human Rights Caucus Forum, Northeastern University, Dec. 7, 2011 Faculty Roundtable, Treatment as Prevention: Addressing Ethical, Policy, and Implementation Conundrums, Northeastern Program on Health Policy & Law, Dec. 12, 2011

2010 Policy paper/analysis, Media:

Health GAP Policy Analysis: Making a Mistake on Treatment – PEPFAR’s New Five-Year Strategy, Feb. 5, 2010 http://www.healthgap.org/documents/WaitinginlinetodiethenewObamaglobalAIDSpolicy.pdf. Brook K. Baker & Asia Russell, Health GAP (Global Access Project) Remarks in the Matter of 2010 Special 301 Review, United States Trade Representative, (March 3, 2010) www.healthgap.org/documents/testimony_HGAPasia301watchlist2010.doc. CTL-for-Health/FTT-with-Health: Resource-Needs Estimate and an Assessment of Funding Modalities (Commissioned paper 2010) http://www.actionforglobalhealth.eu/fileadmin/AfGH_Intranet/AFGH/Publications/CTL-HSS_Funding_Mechanisms_Final.pdf. UNITAID Patent Pool Royalties – A Range of Alternatives (2010). ACTA: Risks of Intermediary Liability to Access to Medicines (June 2010) IMF Macroeconomic Fundamentalism and the AIDS Pandemic, MASS. DISSENT (2010) http://www.nlgmass.org/2010/04/ Truths, Half-Truths, and Untruths: The Obama Administration Defense of its Failing Global AIDS Strategy (August 2010) http://takeanumber.org/facts/truth.html. Letter – Effect of development assistance on domestic health expenditures, 376 LANCET 589-590 (2010) http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)61289-5/fulltext?elsca1=TL-210810&elsca2=email&elsca3=segment. ViiV Licenses vs. the Patent Pool: Unanswered Questions and Unwarranted Antipathy (August 2010) http://www.healthgap.org/trips/viiv_analysis.htm. Joint Expert Letter to Government of Thailand on Including Resident Non-Citizens as Eligible Recipients of Medicines Produced under Renewal of Compulsory Licenses in Thailand (September 29, 2010)

25

Flat Funding for Global AIDS: What are the facts; what is the human cost, ACHIEVE (Fall 2010) http://www.gmhc.org/files/editor/file/r_a_fall10.pdf Comments to the Government of India on the Compulsory License Policy of India (September 30, 2010)

2010 Presentations, Expert Consultations, and Trainings

Global Fund CS/PS Pre-Consultation on the Joint Health System Strengthening Platform, 27-28 January 2010, Geneva Improving Access to Essential Medicines by Implementing the WTO August 30 2003 Decision: Challenges and Opportunities, UNDP, Canadian HIV/AIDS Legal Network, UNICEF, 17 February 2010, New York City Workshop: Reforming Canada’s Access to Medicines Regime (CAMR) Bill c-393 – Finding the Expeditious Solution, UNDP, Canadian HIV/AIDS Legal Network, UNICEF, 18 February 2010, New York City U.S. Campaigns for Universal Access to HIV/AIDS Prevention, Treatment and Care, Health Research Exchange Northeastern University, 19 February 2010 Consultation: Public Interest Analysis of the Global IP Enforcement Agenda, American University Washington College of Law, 23 February 2010, Washington D.C. Panel: Have Fiscal Policies Constrained Needed Responses to the HIV/AIDS Epidemic in Developing Countries, World Bank, 23 February 2010, Washington D.C. World Bank – CSO Health Roundtable: Continuing the Dialogue on Health toward 2015, 8 April 2010, Brussels, Belgium Panel: AIDS Exceptionalism, Health Aid Efficiency Seminar, 13 April 2010, Yale University, New Haven, CT Panel: Film Series: Have You Heard from Johannesburg – Road to Resistance and Hell of a Job, 5 May 2010, Boston, Massachusetts Expert Speaker: Roundtable: Funding for health systems, Seminar: Right to Health: Challenges in funding, health systems, and universal access in development policies, 1 June 2010, Madrid, Spain Expert Consultation – Public Interest Analysis of the International Intellectual Property Enforcement Agenda, June 16-18, 2010, American University Washington College of Law, Washington, D.C. Co-Instructor, Intellectual Property and Access to Medicine Two-Week Intensive, University of Kwazulu-Natal, Durban, S. Africa, July 13-23, 2010 Faculty Discussion, Responding to the Threat of Flat-Funding for Global AIDS, Northeastern U. School of Law, Sept. 13, 2010

Panel, A Case Study in Influencing Policy on a Global Health Level: Driving Down the Price of HIV and TB Drugs, Global Health Student Conference: If Not Now, When? Mobilizing for the Right to Health, Partners in Health, Boston (Sept. 26, 2010)

26

Presentation, International Intellectual Property Regime and Access to HIV Medicines, NUSL International Law Society, October 12, 2010 Co-Facilitator, Panel: Immigrant Communities and Well-being: The Right to Health, the Right to Healthcare, and the Rights of Immigrants with Disabilities, NUSL PHRGE Institute: Beyond National Security: Immigrants and Economic, Social and Cultural Rights, Boston, October 13-14, 2010 Panel, Third Party Liability under the Anti-Countering Trade Agreement and its Impact on Access to Medicines, Consultation with the UN Special Rapporteur on Health, American University Law School, Washington D.C., October 28, 2010

Health GAP: Bending the Curves and Fighting the Global AIDS Pandemic, Evanston H.S., Evanston, Illinois, November 27, 2010 Panel, Recent successes, the crisis in global AIDS funding, and treatment activism, Universal Access and Human Rights: Panel on Global HIV/AIDS Policy and Practice, Northeastern U. School of Law, December 1, 2010 Global AIDS Strategy Retreats, Health GAP, NYC, October 24, 2010; Washington, D.C., December 3-5, 2010 Presentation, Grounded Advocacy – Making Treatment Advocacy Real, HealthRoots Political Economy of Health Seminar Series, Harvard School of Public Health, December 8, 2010 Panel, Launch of Draft Boston Principle on the Economic, Social and Cultural Rights of Noncitizens, NUSL, December 10, 2010

2009 Policy papers/analysis, Media:

GSK Access to Medicines: The Good, the Bad, and the Illusory, Feb. 15, 2009 http://www.healthgap.org/bakeronGSK.htm Skepticism about the Barton/Pfizer Access-to-Medicines Pricing Proposal, Feb. 17, 2009 http://www.healthgap.org/trips/bakeronpfizer.htm The Long and Tortured Road to Adequate, Sustained, and Spendable Domestic and Donor Financing for Health, April 2009 www.healthgap.org/bakeronhealthfinancing.htm Op-Ed with Joia S. Mukherjee, The Danger of IMF Policies, Boston Globe, June 1, 2009 http://www.boston.com/bostonglobe/editorial_opinion/oped/articles/2009/06/01/the_danger_of_imf_policies?mode=PF Expert Submission to Government of India, Ministry of Commerce and Industry: Mashelkar Report II underestimates India’s Right to Define Patentability Standards (October 9, 2009) http://www.healthgap.org/analysis-of-mashelkar-report.htm Brook K. Baker, Matt Kavanagh, and Christine Lubinski, Letter to U.S. Global AIDS Ambassador Eric Goosby, Recommendation for U.S. Treatment Target (October 15, 2009) Interview, Air America – Ron Regan Show, Obama Report Card on Global AIDS, December 1, 2009. Brook K. Baker & Donna Barry, An express line for AIDS treatment, Boston Globe, December 7, 2009

27

http://www.boston.com/bostonglobe/editorial_opinion/oped/articles/2009/12/07/an_express_line_for_aids_treatment/

2009 Presentations, Expert Consultations, and Trainings:

Strategy Retreat, Health Global Access Project, New York City, Jan. 24-25, 2009 Global Pharmaceutical Symposium – Pharma Wars: More ARVs, More than ARVs, More than Africa, Grinnell College, Iowa, Feb. 5, 2009 Response, Achieving Innovation + Access to Global Pharmaceutical Markets: A Discussion with Professor John Barton, Knowledge Ecology International and American University Washington College of Law Program on Information Justice and Intellectual Property, Washington, D.C., Feb. 19, 2009 Participant, Civil Society Forum on the High Level Taskforce on Innovative International Financing for Health Systems, London, March 5, 2009 Macroeconomic Literacy Training, Physicians for Human Rights, ActionAid International USA, Partners In Health, Health Gap, François-Xavier Bagnoud Center for Health and Human Rights, Cambridge, MA, March 12-13, 2009 Consultation on maximizing synergies between health systems and global health initiatives through work on building and sustaining health workforce development, WHO, Washington D.C., March 17-18, 2009 Fourth Expert Consultation on Positive Synergies between Health Systems and Global Health Initiatives, Geneva, Switzerland, March 26-28, 2009 Panel: Perspective on Global Health Delivery and Workshop Leader, GlobeMed Global Health Summit, Northwestern U., Evanston, IL, April 4, 2009 Panel: Making medicine affordable in the developing world: the importance of multi-sectoral collaboration, Harvard International Relations Council's Global Health Day, April 8, 2009 Women and HIV: Myths and Realities of Vulnerabilities and Burdens, Webster College, St. Louis, April 16, 2009 Co-Instructor, SACD Region Parliamentarians: Access to Medicines, University of Pretoria, May 12-14, 2009 Resource Needs Estimates - Bridging the Gap: A Dialogue Between HIV/AIDS and Primary Health Care Advocate, Partners in Health, Stony Brook Conf. Center, NY, May 15-17, 2009 Expert Consultation to develop a framework for performance-based governance for Country Coordinating Mechanisms, Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, May 27-29, 2009 Panel: Biomedical Innovation: Current Issues and Potential Solutions with Perspectives from Academia and Public Policy, Mt. Sinai Medical School, NY, June 1, 2009 Co-Instructor, Intellectual Property and Access to Medicine Two Week Intensive, University of Kwazulu-Natal, Durban, S. Africa, June 29-July 10, 2009

28

Presentation: The Pernicious, Continuing Impact of IMF Macro-Economic Constraint Policies on Domestic and Donor Health Spending, Conference of the Society of Law Teachers of Southern Africa, University of Kwazulu-Natal, Pietermaritzburg, S. Africa, July 14, 2009 Accelerating the Impact of HIV Programming on Health Systems Strengthening: Cape Town Pre-IAS AIDS Conference Meeting July 17-18, 2009. Co-Instructor, OSI Public Health Program Workshop: Intellectual Property, Trade and Access to Medicines in Eastern Europe and Central Asia, Nat’l U. Kyiv-Mohyla Academy, Kiev, Ukraine, Sept. 14-18, 2009 Participant, Global Responsibilities for Global Health Rights Conference, Concert Noble, Brussels, Belgium, October 19-21, 2009; Follow-Up Civil Society Meeting, Antwerp, Belgium, October 22, 2009 Co-Moderator, Panel – Paris Accord Round II: Medical Research and Development, Paris, France October 23-24, 2009 Panel 2: UNITAID HIV/AIDS Patent Pool Initiative, Biotech Patent Pool Workshop, University of California, Berkeley, November 6, 2009 Strategy Retreat, Health Global Access Project, New York City, November 13-15, 2009 Informal Consultation: Advocacy and Communication Priorities for 2010-2011, Global Health Workforce Alliance, Geneva, Switzerland, November 19-20, 2009

2008 Publications, Policy papers/analysis, Newspaper articles:

PEPFAR I vs. Bush’s PEPFAR II: The Only Outcome that Doubles is Deaths; Bush Proposal Dramatically Scales-Back U.S. Funding, Treatment, Prevention & Care (Jan. 24, 2008) Commentary: India and Thailand show the way on access to medicines, Scrip World Pharmaceutical News (Feb. 1, 2008)

Co-Author, Global Health Workforce Alliance, Health Workforce Advocacy Initiative, Principles that should inform National Health Workforce Strategies (Feb. 2008)

Expert Letter to Thai Ministry of Health and Prime Minister, The Legality and Propriety of Thailand’s Public Non-Commercial Use Licenses for AIDS, Heart-Disease, and Cancer Medicines, Feb. 19, 2008 U.S./E.U. Doubletalk on Proposed Trade Sanctions against Thailand for its Continuing Compulsory Licensing Policy (March 21, 2008) Estimates of potential costs savings on second-generation antiretroviral medicines – single-source monopolies vs. patent-pool open competition, Annex 2, Update for the Secretariat on Patent Pool UNITAID/EB8/2008/11/1, June 11, 2008

Expert Comments – Trade Related Aspects of Intellectual Property Rights (TRIPS) and Access to HIV Treatment: Draft UNAIDS, UNDP & WHO Policy Brief, (Sept. 9, 2008) Voluntary Licenses for Local Production of Antiretrovirals in Brazil, (Sept. 9, 2008)

Skepticism about the Health Impact Fund, Nov. 24, 2008 http://www.healthgap.org/trips/bakeronHIF.htm

29

2008 Presentations, Expert Consultations, and Trainings:

NGO Strategy Meeting, Challenging IMF Macroeconomic Restraint Policies, Washington, D.C, Jan. 3, 2008 Expert Opinion: Appeal of the Thai Competition Commission Decision of 27 December 2007Thailand v. Abbott Laboratories, Jan. 14, 2008 Technical Paper: The TRIPS Agreement and the Paris Convention Do Not Require Pipeline Patents, submitted to General Attorney of the Republic of Brazil, Mr. António Fernando Barros e Silva e Souza, Jan. 18, 2008 Civil Society Consultation, Community System Strengthening, Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Jan. 15-16, 2008 Symposium, Tackling Global Health Issues Through Law & Policy, Boston University School of Law, Feb. 2, 2008 Presentation: HIV and the Gendered Politics of Care in South Africa: Paying Community Health Workers, Brandeis University, Waltham, MA, Feb. 12, 2008 Consultation, University of KwaZulu Natal, Certificate Program on Intellectual Property Rights and Access to Medicines, Durban, South Africa, Feb. 22-29, 2008. Guest lecture, IPRs and Access to Medicines, Public Health Law class, University of KwaZulu Natal, Durban, South Africa, Feb. 28, 2008 First Global Forum on Human Resources for Health, Kampala, Uganda, March 2-7, 2008 Breakout Session 5.1. - Advocacy for financing

Macro-economic literacy training workshop

Global Justice Conference, Washington D.C., March 29-31, 2008 Access to Medicines – the New Pharma Wars Answering Questions – Pharma Myths and Facts

Pharma Wars, Universities Allied for Essential Medicine and Physicians for Human Rights Workshop, U. Mass. Medical School, Worcester, MA, March 31, 2008 Global AIDS Strategy Retreat, Health GAP, New York City, New York, April 5-6, 2008 Conference Planning Meeting, Africa Community Health Worker Conference: Policies, Practices and Training, George Washington U., Washington, D.C., April 9, 2008 Presentation: Introduction to Compulsory Licenses, Second Global South Dialogue on HIV/AIDS and Access to Treatment, New Delhi, India, April 18-21, 2008 Presentation: Overview of Civil Society Principles on the IHP+, Civil Society Forum on the International Health Partnerships Plus Related Initiatives, Movenpick Hotel, Geneva (23 May 2008) Winning the Fight against AIDS in Africa, Dorchester People for Peace (June 2, 2008) Health Alliance International: Macroeconomic Literacy Training, Seattle Washington (June 19 and 20, 2008)

30

Intensive Two-Week Course: Intellectual Property and Access to Medicines, University of KwaZulu Natal, Durban, South Africa, July 7-18 (2008) International AIDS Conference, Mexico City, Mexico, August 2-8, 2008

• Skill Workshop Panel – IMF Policies Blocking the Response to HIV/AIDS: A Call to Action, August 4

• Second Expert Consultation – Maximizing Positive Synergies Between Health Systems and Global Health Initiatives, Mexico City, August 5

• B. Baker, T.R. Corcoran, A. Russell, A. Lugg, THPE0961 Abstract: Addressing gaps in financing for HIV and human resources for health, August 7

• A. Russell, A. Boyle, J. Flynn, B. Baker. THPE1032 Abstract: Overcoming Barriers to Registration of Essential AIDS Medicines, August 7

• B. Baker, E. Ombaka. THPE0962 Abstract: The Danger of Drug Donations to the Global Fund, August 7

Expert Consultation Academic Group, Maximizing Positive Synergies Between Health Systems and Global Health Initiatives, Harvard School of Public Health, August 15, 2008 Presentations – Trends in Donor Financing for Health and How and Why the IMF Blocks the Global Response to HIV/AIDS, Joint Retreat CS Delegations, UNAIDS, GF, UNIAID, GAVI, and IHP+, Amsterdam, the Netherlands, September 2-4, 2008 Third Expert Consultation on Positive Synergies between Health Systems and Global Health Initiatives, Geneva, Switzerland, October 2-3, 2008 Global Health Workforce Alliance 1st Coordination Meeting of the Task Forces and Working Groups GHWA, Geneva, Switzerland, October 3, 2008 Panel: Translating critical understandings into real-world change: Policy, Action and Global Health, 2nd Annual Student Global Health Conference Building a Movement: Action for Justice, Boston U. School of Public Health, October 5, 2008 Presentations – Drug Company Economics and the R&D Excuse; TRIPS/TRIPS-Flexibilities/TRIPS-plus and Novartis v. India, Workshop - Bridging the Gap - PharmFree joins Access to Essential Medicines, University of Illinois, Chicago, October 11, 2008. Presentations – IMF Macroeconomic Constraints on Global Health Spending; UNITAID Patent Pool Advocacy, Student Global AIDS Campaign New England Regional Summit, Harvard University, Nov. 8, 2008 Presentation, IMF Expenditure Ceilings and Health Financing in Africa, Conference of Africa Chairs of Health, HIV, Gender & Finance Parliamentary Committees, UKNECA Conf. Center, Addis Ababa, Ethiopia, Nov. 12-14, 2008 Guest Lecture, Global AIDS Campaigns, NU Politics of Health Care Policy, Nov. 19, 2008 Radio Interview, World AIDS Day, WORT-FM Community Radio, Madison, Wisconsin, Dec. 1, 2008 Panel Discussion World AIDS Day, Our Research, Our Responsibility: Making University Innovations Available in Developing Countries, Northeastern U. School of Law, Dec. 2, 2008 Panel, Leadership in the Global Response to HIV/AIDS, Boston University, Dec. 4, 2008

2007 Publications, Policy papers/analysis, Newspaper articles:

31

PhRMA lies and Distortions - Thai Compulsory Licenses, Jan. 26, 2007 http://www.cptech.org/blogs/ipdisputesinmedicine/2007/01/phrma-lies-and-distortions-thai_28.html Mashelkar Report Misstates India’s Right to Define Scope of Patentability and Threatens Access to Medicines, Jan. 26, 2007 http://www.cptech.org/blogs/ipdisputesinmedicine/2007/01/mashelkar-report-misstates-indias.html A deconstruction of Novartis’ defense of its patent case against India, Feb. 7, 2007 http://www.cptech.org/ip/health/c/india/hgap02072007.html A New Low in the Pharma Drug Wars – Abbott Withdraws Seven Medicines in Thailand, (March 14, 2007) http://www.cptech.org/blogs/ipdisputesinmedicine/2007/03/new-low-in-pharma-drug-wars-abbott.html A deadly game of pharmaceutical apartheid, The Nation (Thailand) (March 16, 2007) http://www.nationmultimedia.com/2007/03/16/opinion/opinion_30029417.php NGO Response to Abbott’s announced $1000 price for Aluvia in Low- and Lower-Middle Income Countries (April 10, 2007) http://www.abbottsgreed.com/index.php?title=NGO_Response_to_Abbott_Price_Reduction Abbott’s Blackmail against Thailand continues – Lives Hang in the Balance (April 12, 2007) http://www.essentialdrugs.org/edrug/archive/200704/msg00054.php The Eight Deadly Lies of Big Pharma, The Nation (Thailand) (April 21, 2007) http://www.nationmultimedia.com/2007/04/21/opinion/opinion_30032324.php Brook K. Baker, Sean Flynn and Judit Rius Sanjuan, Specious Arguments on Thailand’s Compulsory Licensing: World’s Premier Law Firm goes to Bat for Abbott, The Bangkok Post (April 27, 2007) http://www.readbangkokpost.com/business/pharmaceuticals/intellectual_property_or_savin_2.php Published Interview in Brazilian Press: Fabiane Leite, Industries Try to Discredit Country, Affirms Consultant, Revista da Fohla – Folha de S.Paulo, May 7, 2007 Health GAP, Essential Action NGO Analysis - The efficacy of compulsory licenses and international cooperation: Thailand and Brazil, the Clinton Foundation HIV/AIDS Initiative and generic companies, and UNITAID and WHO all combine forces to lower AIDS drug prices. Bold moves on several fronts are helping to lower the price of key second-line and improved first-line therapies for HIV/AIDS helping to pave the way to Universal Access by 2010 (May 8, 2007) US Action Plan for Thailand Comes Straight from Big Pharma (May 9, 2007) http://lists.essential.org/pipermail/ip-health/2007-May/011145.html Fixing, Not Just Clarifying, New Trade Policy Rules on Exceptions to Data Exclusivity and D.E. Concurrency (May 15, 2007) Twice As Many Die: Scrutinizing Bush’s duplicitous new AIDS plan, Dollars & Sense 8-10 (July/August 2007) http://www.dollarsandsense.org/archives/2007/0707baker.html Rick Rowden & Brook K. Baker, Background Memo: NGOs Continuing Concern about IMF Policies (August 2007) http://www.actionaidusa.org/pdf/Over-120-International-NGOs-Call-On-IMF.pdf

32

E.U. Demands on Thailand are Based on Lies and Misrepresentations (Aug. 16, 2007) http://lists.essential.org/pipermail/ip-health/2007-August/011586.html The Retreat from Universal Access Goals and Resource Needs for Access to Treatment (Aug. 22, 2007) Co-Author, Civil Society Critique and Proposed Edits to UNAIDS Resource Needs Estimates to Achieve Universal Access to HIV Prevention, Treatment, Care and Support 2009-2015 (Sept. 18, 2007) Comments, Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines, UN Special Rapporteur (Sept. 28, 2007) Simon Collins, Brook K Baker, Gregg Gonsales, Marco Gomes, The dangers of attacking disease programmes for developing countries, 335 British Med. J. 646 (Sept. 29, 2007) http://www.bmj.com/cgi/content/full/335/7621/646 Co-Author, Global Health Workforce Alliance, Health Workforce Advocacy Initiative, Systems Support for Task Shifting (Geneva, Oct. 5, 2007) Comment: Negative Impacts of IMF Fiscal Restraint Policies on Scaling-Up the Global Response to Orphans and Vulnerable Children, Joint Learning Initiative on Children and HIV/AIDS (Oct. 9, 2007) Letter to the Editor, Standing up to Big Pharma, knowing the law and the facts, The Hill (0ct. 24, 2007) http://thehill.com/index2.php?option=com_content&task=view&id=69302&pop=1&page=0&Itemid=73 International Trade and IPR Rules: Myths and Facts (Thailand Conference Paper, Nov. 21-23 2007) Co-Author, HWAI response: Task shifting guidelines, Nov. 26, 2007 Confronting Macroeconomic Constraints that Impact UNICEF’s Commitments (Nov. 29, 2007) Global Health Workforce Alliance, Health Workforce Advocacy Initiative, Principles that should inform National Health Workforce Strategies (Dec. 2007)

2007 Victories – Fewer Patents, More Compulsory Licenses: The Knock-Off Effects of India's Strict Patent Act and Thailand's Compulsory Licenses (Dec. 11, 2007)

2007 Presentations, Expert Consultations, and Trainings:

Strategic options to increase civil society participation in the Global Fund to Fight AIDS, Tuberculosis and Malaria, Amsterdam, the Netherlands, January 5-7, 2007 Strategic Retreats, Health GAP, New York City, Jan. 13-15, March 24-25, 2007, Sept. 8-9, 2007, Dec. 15-16, 2007 Recent Development: India, IPRs, and Access to Medicines, Meeting on India and Access to Medicines, Stop HIV/AIDS in India Initiative, Washington D.C., Jan. 17, 2007 Radio interview, Michael Hatchey, WERS, Boston, aired Feb. 4, 2007

33

Workshop, IPRs, Trade, and Access to Medicines, Global Justice Conference on AIDS, Trade & Child Survival, Washington, D.C., Feb, 3, 2007 2007 Trade Strategy Conference, AFL-CIO, Alliance for Responsible Trade, Citizens Trade Campaign, Public Citizen’s Global Trade Watch, and others, Washington, D.C., Feb. 2, 2007 Novartis v. India Teach-In, NUSL, Feb. 12, 2007 Novartis v. India Teach-In, Harvard AIDS Alliance, Feb. 13, 2007 Radio interview (1 hour), Public Health Radio – Marvin Malek, March 20, 2007 Panel: A Prescription for Global Access: Patent Law and the Availability of Life-saving Medications, Harvard Law School Human Rights Program, April 4, 2007 Workshop, The New Pharma Wars: Novartis v. India and Abbott v. Thailand, Harvard AIDS Tank, April 5, 2007 Workshop, Access to Medicine: The Bigger Access to Medicines Picture – Life Beyond TRIPS, UK Dept. for International Development and the Lancet, London, April 19-20, 2007 Presentation, Human Rights and African AIDS Pandemic, Human Rights Forum, The Violence Prevention and Diversity Program (VPD) at the Center for the Study of Sport in Society, Northeastern University (May 2, 2007) Workshop, The New Pharma Wars: India and Thailand, Partners In Health, May 24, 2007 and July 19, 2007 Radio interview, Wakeup Call (WBAI 99.5FM)New York City May 31, 2007 Presentation: Critique of the Global Architecture for Financing HRH/HSS, Meeting Global Health Workforce Alliance, Advocacy Working Group, Washington, D.C., July 15-17, 2007 NU, Pharmacy class, Patents, Prices, and Trade Agreements: Impacts on the Global AIDS Pandemic, July 18, 2007 Presentation, Patent and Registration Issues Affecting Access to Medicines, Health GAP Allies Strategy Retreat, NYC, Sept. 8-9, 2007 Pharma Wars – The WTO Doha Declaration and Thai Compulsory Licenses, Panel: Intellectual Property and Access to Medicines in the Developing World, DePaul University College of Law and Doctors Without Borders, Chicago, Sept., 20, 2007 http://140.192.59.145/centers_institutes/ciplit/emails/doctors_wo_borders.html Presentation, Student Global AIDS Campaign, New England Strategy Retreat, AIDS as a Symptom: The Broader Issues of Debt, Trade, and Treatment Access, Smith College (Sept. 29, 2007)

Expert Review, Walking the Talk: Putting Women’s Rights at the Heart of the HIV and AIDS Response (VSO-ActionAid 2007) Attendance, Meeting Children's Needs in a World with HIV/AIDS: An International Symposium, Harvard Medical School, Boston, MA, Sept. 24, 2007

Attendance, Food, Nutrition and Health Conference, Cambridge, MA (Oct. 11-12, 2007)

34

Presentation, How the IMF Restricts Health/Education Sector Spending, NUSL Law & Development Study Group (Oct. 11, 2007) Presentation: IPRs and Access to Medicines, ABA SubCommittee on HIV/AIDS, Chicago (Nov. 2, 2007) Globalization, Governance and Development class, Boston University, Nov. 5, 2007

Race, Gender and Class class, Northeastern U., Nov. 7, 2007 Panel, One Campaign – Millennium Development Goals, Boston University (Nov. 15, 2007) Presentation and Paper, International Trade and IPR Rules: Myths and Facts, INTERNATIONAL CONFERENCE ON COMPULSORY LICENSING: INNOVATION AND ACCESS FOR ALL – BANGKOK, NOV. 21-23, 2008

Advocacy in Pharmacy Health Policy class, Northeastern U., Nov. 28, 2007

Dan Rather Reports, New India Patent Act (Dec. 4, 2007) http://www.hd.net/drr240.html

2001-2006 Shorter AIDS-Related Articles

TRANSATLANTIC CONSUMER DIALOGUE, Producing HIV/AIDS Medicines for Export/Import under TRIPS, Articles 31(f), (k) and 30 (November 6, 2001) (Presented Dec. 3-4, 2001, TACD Conf.) Activist Response to the African AIDS Pandemic, Spark Magazine (Summer 2002). Brook K. Baker and Michael Hochman, Death Sentence, The American Prospect online (Dec. 20, 2002). Intellectual Property Rights and Access to Medicines: The USTR’s Dismal Economics and Death by Patent, Econ-Atrocity – Center for Popular Economics online (Dec. 2002). Responding to the African Aids Pandemic, Mass Dissent (Mass. Chapter of the National Lawyers Guild, April 2002). Demographics of the African AIDS Pandemic, Mass Dissent (Mass. Chapter of the National Lawyers Guild, May 2002). U.S. Trade Policy Intensifies the AIDS Pandemic, Mass Dissent (Mass. Chapter of the National Lawyers Guild, March 2003) Women and the Global AIDS Pandemic, Mass Dissent (Mass. Chapter of the National Lawyers Guild, March 2004) INDIA’S 2005 PATENT ACT: Death by Patent or Universal Access to Second- and Future-Generation ARVs? 93 Global AIDSLink 17 (Sept./Oct. 2005). Pills Without Providers: Where are the Health Workers?, 15(4) ACRIA Update 6-8 (2006).

Price-cut handcuffs: Thailand must stand up to Merck’s counter-offensive and fully implement its compulsory licence on efavirenz, 196 Third World Resurgence 23-24 (Dec. 06) http://64.233.169.104/search?q=cache:71AEroa28IQJ:www.twnside.org.sg/title2/resurgence/196/cover6.doc+price+cut+handcuffs&hl=en&ct=clnk&cd=1&gl=us&client=netscape-pp .

35

U.S. Pursuit of TRIPS-plus Intellectual Property Rights and its Opposition to Thailand’s Lawful Compulsory License for Merck’s Efavirenz Undermines its own Global AIDS Initiative, Threatening a Fivefold Increase in the Costs of Medicines, Dec. 22, 2006 http://lists.essential.org/pipermail/ip-health/2007-January/010470.html

2005-2006 Policy papers and analyses (selected)

Health GAP Report: Missing the Target – An Assessment of Major Multilateral and Bilateral HIV/AIDS Programs (Dec. 1, 2005) NGO Policy Brief: Myths and Realities Impact of U.S.-Thai FTA on Access to Medicines (Jan. 25, 2006) Health GAP Report - Between the Lines - GAO Report on PEPFAR Prevention Programs: U.S. Abstinence/Being Faithful-Only Programs Produce Stigma and Death (April 5, 2006) Health Gap Policy Review of HRH/HSS Proposals in the 2005 World Bank Global HIV/AIDS Program of Action (April 7, 2006)

Fundamental Criteria for HRH/HSS Campaigns (June 2006) NGO POLICY BRIEF: Free Trade Agreements and Intellectual Property Doom Access to Medicines (August 16, 2006)

NGO POLICY BRIEF: Drug Companies’ Negative Role in Access to Medicines (August 13, 2006) Paying for Care Labor: Choices and Contradictions in a Community Healthcare Worker Campaign (September 2006) Market Dynamics and The Global Fund: Background Research And Analysis (McKinsey & Company, 30 August 2006) Civil Society Critique Re: Competition Fostering (September 2006) Long Term Global Funding Need and the Right Global Fund Size: The Case for Option C ($8-$11 billion/year by 2010) (September 2006) U.S. Pursuit of TRIPS-plus Intellectual Property Rights and its Opposition to Thailand’s Lawful Compulsory License for Merck’s Efavirenz Undermines its own Global AIDS Initiative, Threatening a Fivefold Increase in the Costs of Medicines, Dec. 22, 2006

2001-06 AIDS- Related Consultations, Submissions, and Selected Presentations

Next Steps and Strategies on Bilateral Free Trade Agreements Panel Presentation: Using FTA Side Letters and Congressional Letters to Authorize Waiver of Data Exclusivity and Linkage

Consumer Project on Technology (Nov. 16, 2006) La Propiedad Intelectual Desde La Perspectiva Del ALBA. Contribuyendo A La Conformación De Un Mundo Multipolar.

Presentation: The PhRMA Wars: U.S. 301 Watch Lists and Free Trade Agreements Presentation: The WTO TRIPS Agreement, TRIPS Flexibilities, and Access to Medicines

Caracas Venezuela (November 4-5, 2006)

36

Caribbean Regional Workshop On Intellectual Property And Access To Medicines, presentation, Patents & Trade Agreements- Implications on access to HIVAIDS medicines, Round Table Session II Regional Procurement of Drugs & Access to Medicine, UNDP, PAHO, CARICOM, PANCAP, Trinidad, October 23-26, 2006 Panel, Law and the Global AIDS Pandemic, NU School of Law Student Global AIDS Campaign, Sept. 21, 2006 Panel, Reflections on the 16th International AIDS Conference: Time to Deliver, Northeastern University, Sept. 21, 2006. Panel, Forum on University Innovations and Global Health, Universities Allied for Essential Medicines, University of Pennsylvania, Sept. 14, 2006 XVI International AIDS Conference, Toronto, Canada, August 12-18, 2006

• J. Cohn, B.K. Baker, A. Russell, R. Weissman, MOPE0978 Abstract: Impact of IMF macroeconomic policies on scaling up AIDS spending and spending for HRH/HSS

• Press Conference: Call for a Moratorium on Free Trade Agreements and Enforcement of TRIPS-plus IPRs

• OSI Consultation: Civil society’s role in the Global Fund to Fight AIDS, TB, and Malaria

• Task Force: International Coalition on IPRs and Access to Medicine Panel: Women, HIV, and Human Rights – Access to Treatment, University of Toronto

Presentation: Trade, Intellectual Property, and Access to Medicines: How Data Exclusivity and Registration/Patent Linkage Bar Access to Generic Drugs, Conference of Society of Southern Africa Law Teachers, Cape Town, South Africa, July 11, 2006 Participant: Global Fund Partners’ Forum, Durban, South Africa (July 1-3, 2006). Colloquium: Intellectual property rights, access to medicines, and human resources for health challenges in international HIV/AIDS advocacy, University of Cape Town Law Faculty, South Africa, June 22, 2006 Magistrate’s Training, HIV/AIDS in the Courtroom and the Community, Limpopo Province (June 28, 2006) Consultation, Centre for Positive Care, Limpopo, South Africa (June 25-26, 2006) Consultation, Ethekwini Municipality City Health Unit (June 15, 2006) Consultations, Children’s Rights Centre (June 13, July 13, 2006) Roundtable Participant, Women, War, and Violence: Liberia, Digital Video Conference with Liberian women’s organizations and Liberian educators co-sponsored by U.S. Embassy in Liberia and Department of Women’s Studies, Northeastern University (May 8, 2006).

Expert Review Committee, The Interfaith Center on Corporate Responsibility report "Benchmarking AIDS" (2006). Panel, Human Trafficking Awareness Day, Northeastern University, April 10, 2006

37

Panel, Structures of Militarization and War for Women’s Rights and Health, Conference on Women, War, and Violence: The Local, National, and Global Impact of War on Girls and Women, Northeastern University (March 18, 2006). Presentation, Effective Activism and Future Activism in Fighting the Global AIDS Pandemic, Mass. Lawyers Guild (March 14, 2006). Consultation: Strategy and Business Plan for a Global Health Workforce Alliance, World Health Organization, Oslo, Norway; co-chair break-out group – disseminating information and advocacy (March 12-13, 2006). Presentation: Access to Essential Medicines: Overcoming Intellectual Property and Health System Barriers, UMass Access to Access to Essential Medicines and Physicians for Human Rights, U. Mass. Medical School (Feb. 28, 2006). Workshop: Intellectual Property, Free Trade Agreement, and Sustainable Development, The Center for International Environment Law, American University Washington College of Law, Third World Network, Sociedad Peruana De Derecho Ambiental, and Trade Law Centre for Southern Africa (Feb. 27, 2006). Consultation, Office of Senator Leahy: Life-Saving Medicines Export Act (winter 2005-summer 2006) Consultation, Office of Senator Durbin: S. 3775 African Health Capacity Investment Act of 2006 (spring & summer 2006). Colloquium, Globally Engaged Activism on HIV/AIDS in South Africa, South Africa Reading Group, New York Law School (Feb. 17, 2006). Presentation: Dismantling Barriers to Access: Intellectual Property Regimes, Free Trade Agreements, and Health Sector Structural Adjustments, AIDS Tank, Harvard University (Feb. 16, 2006). Commentor, Rashida Manjoo, Recent Development of Social, Economic, and Cultural Rights in South Africa, Northeastern U. School of Law Human Rights Program (Feb. 7, 2006). NEW YORK LAW SCHOOL – SOUTH AFRICA READING GROUP: Presentation: International Human Rights Activism and HIV/AIDS – Access to Medicines and Access to Treatment, February 17, 2006 VENEZUELA INTERNATIONAL SEMINAR – INTERNATIONAL TRADE AND ACCESS TO MEDICINES: Presentation: Placing Access to Medicines on the Human Rights Agenda; Presentation: Bird Flu/Tamiflu Crisis; Presentation: Simplifying Compulsory Licensing Procedures, Caracas, November 17-18, 2005 WORKING GROUP: PUBLIC HEALTH AND THE HUMAN RIGHTS FRAMEWORK - Framing the Relationships between Human Rights and Public Health (with Wendy Parmet), Northeastern University School of Law, REALIZING ECONOMIC, SOCIAL AND CULTURAL RIGHTS: COMMUNITIES, COURTS AND THE ACADEMY , June 16-17, 2005 NGO/HEALTH GAP SUBMISSION TO THE INDIAN TECHNICAL EXPERT GROUP ON PATENT LAW ISSUES: It Is Fully Trips-Compliant To Limit The Scope Of Patentability For Pharmaceutical Substances To “New Chemical Entities” Only, Sept. 22, 2005

38

Workshop, New England AIDS Education and Training Center, University of Massachusetts Medical School, New England HIV Education Consortium, Codman Square Community Health Center, Recent Developments: Progress and Bottlenecks in Responding to the Global AIDS Pandemic, March 4, 2005 Consultation, Future Directions for the International AIDS Conference, Geneva, March 18, 2005 Consultation, World Health HIV/AIDS Unit and Human Resources for Health Unit, Geneva, March 17, 2005 Consultation, U.K. Dept. for Int’l Development, Access to Medicines and International Issues, March 2005 Youth AIDS Summit Workshops, Trade, Intellectual Property, and Access to Medicines; Poverty, Racism, and Globalization: Structural Determinants of the Global AIDS Pandemic, George Washington University, Feb. 27, 2005 Press Conference, Global AIDS Alliance, Critique of Proposed India Patent Legislation, Feb. 25, 2005 Consultation and Presentations, ASEAN-Rockefeller Foundation Project: Regional Workshop on Intellectual Property Laws Review and Capacity Building on IPRs Related to Public Health in the ASEAN Region, Bali (Dec. 10-12, 2004) Faculty Colloquia NU School of Law

New Barriers to Accessing Medicines: U.S. Attacks on WHO Prequalification of Fixed-dose Combination ARVs and Drug Registration Catch 22’s, October 14, 2004 Intellectual Property and Trade Issues Affecting Access to Medicines, December 11, 2002 African AIDS, Globalization, Pharmaceutical Apartheid, and Legal Activism, March 21, 2001

Boston Social Forum (July 23 & 24, 2004) Organizer and Panelist: Globalization, Pharmaceutical Apartheid, and the African AIDS Pandemic Panelist: Global Trade Agreements, Democracy and Health

XV International AIDS Conference, Bangkok, Thailand (July 11-17, 2004)

Panelist: Trading Away Health? Free Trade Agreements and HIV/AIDS Treatment Access Skills Building Workshop: Access to Treatment, public health, and the U.S.-Thai Free Trade Agreement

Consultation, U.K. Dept. for Int’l Development, London (June 10, 2004), Processes and Issues for Improving Access to Medicines: Willingness and Ability to Utilize TRIPS Flexibilities in Non-Producing Countries, Workshop, Center for Popular Economics, Trade, IPRs, and AIDS Activism, Amherst, MA, June 5, 2004 Conference Panel, Striving for Equity in South Africa: International Health Partnerships, South Africa Partners, Boston, MA (May 18, 2004).

39

Panel, Witnessing Democracy in South Africa: Art, Politics, and Change, Northeastern U. (May 8, 2004). Participant, Conference on Fixed-Dose Combination (FDC) Drug Products: Scientific and Technical Issues Related to Safety, Quality and Effectiveness, Gaborone, Botswana, March 29-30, 2004. Presentation, New Barriers to Accessing Medicines: U.S. Attacks on WHO Prequalification of Fixed-Dose Combination ARVs and Drug Registration Catch 22’s, Centre for AIDS Programme of Research in South Africa (March 26, 2004). Panelist: AALS Annual Meeting, Joint Program of Sections on Africa and Minority Groups, HIV in Africa, Atlanta, January 5, 2004. Meeting of Global Experts, HIV Treatments, Vaccines and Microbicides, November 17-19, 2003. Panel Organizer and Presentation, Intellectual Property, Globalization, and Public Health/Public Goods, Rethinking Ideology & Strategy: Progressive Lawyering, Globalization and Markets, Northeastern University School of Law, November 6-8, 2003. Call to Action: Africa Action’s End Global Apartheid – National Teach-In, Boston, Securing Africa’s Right to Health: Grassroots Perspective on Fight the AIDS Crisis in Africa, October, 1, 2003 World Bank Consultation, The Role of Generics and Local Industry in Attaining the Millennium Development Goals, in Pharmaceuticals and Vaccines, June 2, 24-25, 2003. Presentation: Puget Sound HIV/AIDS Alliance Conference, Global AIDS Activism, May 31, 2003. Panelist: European Law Research Center Spring Conference 2003, Progressive Lawyering and Social Movements: Case Study Global AIDS, April 13, 2003.

Presentation: University of Massachusetts Medical School, Global AIDS, Patents, and Pharmaceutical Apartheid (April 3, 2003). Presentation: New England Clinicians’ Workshop, Teaching Legal Skills in South Africa: A Transition to International HIV/AIDS Solidarity, February 7, 2003. Presentation: JEA/NPSA National High School Journalism Conference, Why Should Young Journalists be Concerned about HIV/AIDS in Africa, November 10, 2001.

Panelist: Conference of the Trans Atlantic Consumer Dialogue, IP and Health Care Technologies: Implementing Paragraph 4 of the Doha Declaration on TRIPS and Public Health (October 31, 2002). Panelist: International Law Association of the New York Bar Association, International Law and the Global HIV/AIDS Crisis, October 26, 2002. Strategy Session – MSF and Others: The Free Trade Area of the Americas (FTAA), Intellectual Property Rights & Access to Medicines (October 3, 2002).

40

Participant: Yale University Workshop on Access to Essential Medicines and University Research: Building Best Practices, September 25, 2002. Presentation: Northeast Regional Conference of the National Lawyer's Guild, African AIDS and Legal Activism, September 22, 2002. Presentation: XIV International AIDS Conference in Barcelona, Spain, Satellite Meeting (Health GAP and Doctors Without Borders) Time To Treat: Transforming Aids Treatment From Right To Reality, The Global Fund To Treat AIDS, TB, And Malaria: Fulfilling Or Betraying The Promise Of Treatment, July 7, 2002. Policy Roundtable Discussion: Harvard Health Caucus, Building a Legal Framework for Global Health: How can the US and UN Work to Reduce Global Disparities, March 20, 2002.

Presentation: Harvard Institute for Health and Social Justice, Death by Patent: The International Intellectual Property Regime, July 17, 2001 Conference Organizer: Boston Global Action Network Africa AIDS Project, Access to Affordable Medicines under National and International Intellectual Property Regimes, April 7, 2001 Presentation: Gordon College Convocation, Global Causes and Global Solutions to the African AIDS Pandemic (April 2, 2001)

2003 Attendance Multi-Lateral Forums and Conferences

First South Africa AIDS Conference, Durban, South Africa, August 4-7, 2003. Bi-Annual Congress, Treatment Action Campaign, Durban, South Africa August 1-3, 2003. World Health Assembly (May 18 to 25, 2003) Geneva, Switzerland Board Meeting of the Global Fund to Fight AIDS, TB, and Malaria (January 28 to February 2, 2003) Geneva, Switzerland.

2001-06 Student Group and Classroom Presentations (Selected)

NU, Introduction to Women’s Studies class, Responding to Women’s Heightened Vulnerability to HIV/AIDS, October 12, 2006 NU Law, International Human Rights Law Research Seminar: Race, Gender, Culture, Nation in Post-Colonial Perspective, HIV/AIDS and Human Rights Activism, Sept. 26, 2006

NU, pharmacy class, Global AIDS and Pharmaceutical Apartheid, July 20, 2006 NU, Introduction to Women’s Studies class, Responding to Women’s Heightened Vulnerability to HIV/AIDS, January 26, 2006 NU World AIDS Day Forum: Responding to Women’s Heightened Vulnerability to HIV/AIDS, December 1, 2005 Harvard Law School Advocates for Human Rights, Activism and the AIDS Pandemic in Africa, September 24, 2005 Discussant, United Against AIDS Summit, Activist Lunch, Harvard, April 23, 2005 AIDS Tank, Trade, Intellectual Property, & Access to Medicines, Harvard University, Feb. 17, 2005

41

NU World AIDS Day, Forum: Activist Response to the Global AIDS Pandemic and to U.S. Policy Miasma; Panel: Global AIDS Pandemic, December 1, 2004 Why Me? Teach-In, African AIDS Activism, Tuft University, October 24, 2003 University of Massachusetts Medical School (April 3, 2003) Global AIDS, Patents, and Pharmaceutical Apartheid. NU pharmacy class, Global AIDS and Pharmaceutical Apartheid, February 25, 2003, July 22, 2004, July 13, 2005. NUSL, Int’l Trade Law class, Treatment Activism and Access to Medicines, Feb. 7, 2003 NUSL Committee Against Institutional Racism, Global AIDS Pandemic, October 17, 2002.

Cambridge College Workshop – Pharmaceuticals and Health Care Reform, International Issues in Access to Medicines (March 9, 2002)

Harvard Activist Training: Multinational Corporate Complicity In The Aids Pandemic, On The Impact Of Globalization On The Aids Pandemic, And On Treatment Activism And The Coca-Cola Campaign (October 8, 2002). MIT Multinational Corporate Complicity and the AIDS Pandemic (October 8, 2002). NULS Committee Against Institutional Racism – Community Forum, Racial Issues in the South African AIDS Pandemic (January 24, 2001)

II. LEGAL EDUCATION-RELATED PUBLICATIONS AND ACTIVITIES COURSE BOOK Peggy Maisel, Lesley Greenbaum, and Brook K. Baker, TEACHERS’ MANUAL: INTRODUCTION TO LAW AND LEGAL SKILLS (Butterworths S. A. 2001) Published Articles - Refereed Learning Through Work: An Empirical Study of Legal Internship, co-authored with Daniel J. Givelber, Jack McDevitt, and Robyn Miliano 45 J. Legal Educ. 1-48 (March 1995) Learning to Fish, Fishing to Learn: Guided Participation in the Interpersonal Ecology of Practice, 6 Clinical L. Rev. 1-84 (1999) Published Articles - Non-Refereed

Beyond MacCrate: The Role of Context, Experience, Theory and Reflection in Ecological Learning, 36 Ariz. L. Rev. 287-256 (1994).

Transcending Legacies of Literacy and Transforming the Traditional Repertoire:

Critical Discourse Strategies for Practice, 23 William Mitchell L. Rev. 491-563 (1997). Traditional Issues of Professional Responsibility and a Transformative Ethic of Client

Empowerment for Legal Discourse, 34 New England L. Rev. 809-906 (2000).

42

Language Acculturation Processes and Resistance to In'doctrine'ation in the Legal Skills Curriculum and Beyond: A Commentary on Mertz's Critical Anthropology of the Socratic Doctrinal Classroom, 34 John Marshall L. Rev. 131-61 (2000). Incorporating Diversity and Social Justice Issues in Legal Writing Programs, 9 Perspectives 51-57 (2001).

Brook K. Baker, Practice-Based Learning: Emphasizing Practice and Offering Critical Perspectives on the Dangers of “Co-op”tation, 56 N.Y.L.S. L. Rev. 401-439 (2011-12) http://www.nylslawreview.com/wordpress/wp-content/uploads/2011/11/Baker.Practice-Based-Learning.pdf

Book chapters

Back to the Future: Co-op and Northeastern’s Twice Born Law School, TRADITION AND INNOVATION: REFLECTIONS ON NORTHEASTERN UNIVERSITY’S FIRST CENTURY (Deborah Rhode ed., 1998)

Dissemination of Research to Reform Practice: Fishing (and Lawyering) to Learn, in Handbook for Research in Cooperative Education and Internships (Patricia L. Linn, Adam Howard and Eric Miller, eds., Lawrence Erlbaum and Associates, 2004).

CONFERENCE PAPERS (Unpublished):

Challenges Facing a Proposed WIPO Treaty for Persons Who are Blind or Print Disabled, (Law and Society Association Annual Meeting – Session: Law, Society, and Technologies: A Disability Perspective, June 2, 2013) http://keionline.org/node/1723 “Self”-Directed Learning Post-Modernized: Autonomy, the Search for Self, and Self-Realization in Law Student Work Experience, (Practice Oriented Education: Transforming Higher Education, Northeastern University, April 25, 2001) Practice-Based Learning – Emphasizing Practice, Practice Oriented Education: Transforming Higher Education, Northeastern University, April 27, 2001); Practice Oriented Education Mini-Conference, Northeastern University, May 2, 2000 Pedagogical Justifications and Empirical Investigations of Teaching Assistant Effectiveness, 1-28 (1999 Association of Legal Writing Directors Biennial Conference, New England Law School, July 29, 1999)

Critical Pedagogies for the Classroom and Critical Discourse Strategies for Practice, 1-22 (Legal Writing Institute, July 18, 1996).

Learning to Fish, Fishing to Learn: Theory and Data in Support of Cooperative Learning, 1-16 (National Society for Experiential Education, November 9, 1995).

A Theory of Contextualized, Ecological Learning and its Implications in Research, Analysis, and Writing Programs, 1-41 (Legal Writing Institute, July 28, 1994).

What is Said, What is Meant, What is Understood: Interpretative Communities and Legal Discourse, 1-12 (Legal Writing Institute, August 1, 1992). Teaching Values Through Legal Writing, 1-17 (Legal Writing Institute, August 1, 1992).

43

Conventionalism, Contextualism, and Interpretative Communities: Are These Helpful Theories for Legal Writing Instructors? 1-10 (Midwest Conf. of the Legal Writing Institute, July 16-17, 1991).

Choices in Feedback on Legal Writing: Reader- Response, Priorities, Reinforcement, and Directiveness, 1-13 (Midwest Conference of the Legal Writing Institute, July 16-17, 1991).

Diagnosing Legal Writing Problems: Theoretical and Practical Perspectives for Giving Feedback, 1-22 (Legal Writing Institute, July 28, 1990). Mike Meltsner, Dan Givelber, Jim Rowan & Brook Baker, Training for Competency in Getting and Giving Supervision, (UCLA-Warwick International Clinical Conference, Winter 1986-87) CLINICAL TEACHING MATERIALS: Casterbank v. South End Family Planning Clinic, Inc., wrongful discharge case (1981). Heller v. Sherman, premise liability case co-developed with Mary O'Connell & Jim Rowan (1981). Nelson v. Sherman, a contract dispute (1987), NU Gift Problem, (1987). United States v. Smith, a complex, federal criminal civil rights case (1987). Agar v. Housing for Humanity, Inc., a low-income cooperative housing simulation involving breach of security and multiple public-interest issues (1991).

Singh v. Expanded-Care, Inc., a 200-page whistleblower-protection case simulation, co-developed with Melinda Drew (2002)

Negotiation Course Materials consisting of five major simulations: State v. Bins, a criminal plea bargain (modified from work by Michael Meltsner); N.O.W. Conflict of Interest case, an intra-firm mediation/negotiation (modified from work by Brian Lutch and Gilda Tuoni); Kosmo v. Slabi, a dispute over a mortgage contingency deposit; Homelessness Mediation, a four-party public sector mediation (co-authored with James V. Rowan); and Maxwell v. Garcia Transportation Co. Inc., a wrongful discharge case (co-authored and modified from materials developed by instructors at Boston College Law School) (1987-1988). Negotiation Course Materials: Seven simulations relating to the Africa AIDS Pandemic: Medicines Patent Pool Negotiation; Regulatory Implementation – Access to Medicines; Competition Commission Case; Doha Declaration Negotiations; Mother-to-Child-Transmission negotiation; US-SACU Free Trade Negotiations (2001-2016).

Analytical Skills Workshop Course Materials consisting of 15-20 exercises and other instructional materials (1987-2017).

Urban Legal Laboratory Course Materials: upper level simulation materials and assignments to teach planning, mediation, interviewing, counseling, negotiation, pleading, discovery, and trial practice at Boston College (1986).

Introduction to Lawyering and Professional Responsibility. Co-authorized simulation and assignments for first-year skills course at Boston College (1986). New York Department of Social Services Legal Department. Co-authored training materials with James V. Rowan on homelessness to teach lawyering skills to legal staff (1986).

44

LEGAL EDUCATION-RELATED CONFERENCES AND PRESENTATIONS

Panelist: The Global Response to the Zika Pandemic, Northeastern University (April 6, 2016) Health Policy Round Table, Response to Ebola, NU Health Policy and Law (Nov. 18, 2014) WIPO Treaty for the Blind, Panel: Law, Society, and Technologies: A Disability Perspective; Roundtable – Keeping Lawyers Relevant: How Experiential Legal Education Can Effect Social Change, Int’l Meeting of the Law & Society Assn., Boston MA, June 2, 2013 Commentator, Elizabeth Trujillo, Public/Private Partnerships in Trade and Development, Northeastern U. School of Law Faculty Colloquium (May 8, 2013) Commentator, Panel – Reimagining Competencies in Experiential Education in Law: Mission, Goals, and Vocabulary, Inaugural National Symposium on Experiential Education in Law, Northeastern U. School of Law, October 27, 2012 International Human Rights Clinicians Meeting, Florida Int’l U. School of Law, Miami, Feb. 3-4, 2012 Panel: Organizing and Delivering Clinical Legal Education, Clinical Theory Workshop 25th Anniversary Conference, New York Law School, Oct. 1-2, 2010 Presentation: Northeastern University Practice-Oriented Education Retreat, The Promise and Danger of Practice-Based Learning (November 18, 2002). Presentation: Bi-Annual Conference of the Legal Writing Institute, Cross-Cultural Challenges: Teaching LRW in South African - Lessons in International Solidarity, May 30-June 2, 2002. Presentations: New England Legal Writing Consortium,

Diversity Training for Legal Writing, June 15, 2001 Building Relationships Between Students and Teachers That Encourage Receptivity to Feedback, March 23, 2001

Presentation: Northeastern University POE Mini-Conference – Good Practices for Practice-Oriented Education: Demonstrations and Discussion (November 3, 2000)

Presentation: Languages of Race, Feminism, Philosophy, and Anthropology: Translating for the Legal Skills Classroom Conference, John Marshall School of Law Teaching Lawyers the Language of Law: Legal and Anthropological Translations – Response, November 4, 1999.

Panel Presentation: AALS Conference in New Orleans on “New Opportunities in Legal Exchange” - A Sabbatical In South Africa: Cross-Cultural and Political Perspectives on Educational Reform (Jan. 10, 1999) Presentation: Learning From Practice: Developments in Externship Pedagogy Columbus School of Law, Learning Through Guided Participation in the Interpersonal Ecology of Practice (Washington D.C., March 6, 1998)

Faculty Colloquia: Northeastern U. School of Law

Dilemmas of Cross-Cultural Lawyering and Teaching: Six Months In South African Clinics, April 8, 1998.

45

Critical Pedagogies for the Classroom and Critical Discourse Strategies for Practice, September 28, 1995. A Theory of Ecological Learning, January 27, 1994.

Presentations: Legal Writing Institute and Association of Legal Writing Directors Conferences: See titles of Conference Papers July 1990, July 1991, August 1992, July 1994, July 1996, July 1999

Presentations: New England Clinical Law Teachers Conferences:

Dealing with Issues of Stereotype Threat in Clinical Practice (December 3, 1999) Learning Through Guided Participation in the Interpersonal Ecology of Practice” (March 27, 1998)

Dilemmas of Cross-Cultural Lawyering and Teaching: Six Months In South African Clinics (Nov. 21, 1997) Critical Writing Strategies for Clinicians (Feb. 2, 1996) A Theory of Ecological Learning (March 1995) Evaluating a Case for Settlement (Feb. 1985)

Presentation: New York Law School - Clinical Theory Workshop: Learning Through Work: An Empirical Study of Legal Internship (Dec. 6, 1996)

Presentation: Southern New England School of Law, Participant Practical Skills Forum: Work-Based Pedagogies (Dec. 12, 1996)

Presentations: Northeastern University Asa S. Knowles Office for the Study of Work and Learning,

Learning to Fish, Fishing to Learn: Theory and Data in Support of Learning on Co-op (Sept. 24, 1996)

Ethical Dilemmas of Helping Students Face Ethical Dilemmas on Co-op, Part IV (April 9, 1998) Panel on Political Correctness, New England Cable Network News, April 27, 1992. Massachusetts Bar Association, Young Lawyers Div., Planning for Negotiations (Nov. 22, 1988) TEACHING, CONSULTING, COLLOQUIA AND PRESENTATIONS IN SOUTH AFRICA

Development student and instructor course materials Fatima Khan vs. Anil Singh (sexual harassment simulation) – Legal Skills in Context, University of KwaZulu Natal, Durban, S. Africa, April-May 2011 Co-Author, Practical Guide to Writing Research Papers and Dissertation, University of KwaZulu Natal, Durban, S. Africa, May 2011 Co-Lecture LLB Course, Teaching Legal Skills, University of KwaZulu Natal, Durban, S. Africa, Feb.-May 2011 Co-Lecture LLM Course, HIV and the Law, University of KwaZulu Natal, Durban, S. Africa, Feb.-May 2011 Proposal to Teaching and Learning Office, Integrated First and Second Year Skills Program, University of KwaZulu Natal, Durban, S. Africa, March 2011 (funded for over R800,000)

46

Consultation, Law Faculty, Student Development Program, and Vice Chancellor, University of Zululand, April 6, 2011 LLM Research Workshop, University of KwaZulu Natal, Durban, S. Africa, February 19, 26 and March 5, 2011 Consultation, Integration of University of Durban-Westville and University of Natal-Durban Clinical Programs, University of KwaZulu Natal, June 13, 2006 Colloquium: Mentoring Junior Faculty to Ensure Academic Success: Challenges and Possibilities, University of Cape Town, June 21, 2006 Presentation: Mentoring Junior Faculty to Ensure Academic Success: Challenges and Possibilities, University of KwaZulu Natal, July 12, 2006

Graduate Student Workshop, Legal Research and Writing, University of KwaZulu-Natal, Westville Campus (March 27, 2004). UDW Law Clinic, March-April 2004, August, 2003, April – May 2002, supervision of students re client representation and classroom instruction on HIV/AIDS-related issues (mother-to-child-transmission, post-exposure prophylaxis) University of Natal-Durban, May 2002, Instructing Law Students – Creating A Pedagogical Alliance July 2000 Congress of the Society of Law Teachers of Southern Africa: Intensifying the Writing Skills Curriculum in Law Faculties and Diagnosing Legal Writing Problems. South African Regional Client Counseling Competition Training student contestants and judges (February 15-19, 1999) UND Faculty Colloquium Diagnosing Legal Writing Problems: Theoretical and Practical Consequences for Giving Feedback (March 1, 1999) including 21-page colloquium paper Saturday Workshop for Teaching Legal Skills Course: Multi-Culturalism, Running Your Tutorial, and Feedback on Student Writing UND (Feb. 27, 1999) Co-Instructor Teaching Legal Skills Course UND (February 21 - March 13, 1999) Co-Author Course Materials Introduction to Law course and Teaching Legal Skills Course Lecture: Critical Perspectives on U.S. Legal Education and U.S. Law, Professional Legal Training Course UDW (March 1999) UDW Faculty Colloquium - Expanding the Skills Curriculum - First Year and Beyond (March 1999) UDW Seminar - Lawyering in the Year 2000. This three-day seminar focused on practical skills; values and ethics, as well as cultural diversity issue in S. African law (May 25-27, 1998) UDW Faculty Colloquium - Building an Intellectual Community (June 10, 1998) UDW Faculty Colloquium - Teaching Effectiveness (June 23, 1998)

47

Association of University Legal Aid Institutions - KwaZulu Natal Clinicians Meeting (June 2, 1998) Training Academic Development Program Tutors at UDW (June 10, 1998) Discussion of Initial Report by the Legal Aid Transformation Team to the Minister of Justice (June 21, 1998) Staff Seminar, Creating a More Active, More Critical Pedagogy at Durban-Westville (July 1, 1997)

Staff Seminar, Teaching Law Through Practice-Based Learning, Virtual Realities, and Other Authentic Ways of Learning, University of Natal, Durban, South Africa (May 9, 1997)

Law Students Council Workshop, American Perspectives on Disciplinary Rules, University of Durban-Westville, Durban, South Africa (April 13, 1997)

Guest Lecture, Overview of American Systems of Taxation, University of Durban-Westville, Durban, South Africa, March 3, 1997

Co-Instructor Practical Skills Training and Jurisprudence Courses, University of Durban-Westville, February-June 1997 Clinical Instructor University of Durban-Westville and University of Natal-Durban, February-June 1997

OTHER ACTIVITIES IN SOUTH AFRICA Workshop on Masculinity and Schooling, Innovation Centre, University of Natal, Durban, South Africa, July 5-6, 1997 University of Durban Gender Studies Seminar, Durban, South Africa, March 13, 1997 COSATU KNZ Provincial Gender Conference, Workshop on Gender Sensitivity and Self-Reliance, Durban, South Africa, February 15, 1997 UMKHOSI KA DR JL (MAFUKUZELA) DUBE (Peace Ceremony in honor of ANC Founder, Dr. Dube), Ohlange High School, Inanda, South Africa, February 16, 1997 Regular participation in the University of Durban-Westville’s Women’s Forum Consultation on University Disability Policy for the University of Durban-Westville

Consultation with the Durban Legal Resource Center on the Nadesan v. KwaZulu Natal Department of Education

PROFESSIONAL AND UNIVERSITY SERVICE: PhD Dissertation Supervision

Chair, João L. Carapinha, Northeastern University Law and Public Policy, 2011-12

48

Gender and Medicines Access and Use Among Adults with Chronic Illnesses in South Africa: A Human Rights Perspective

Co-Chair, Enga Kameni, University of Pretoria, Faculty of Law, Centre for Human Rights, 2010-2015

Implementation of TRIPS Public Health Flexibilities in the African Intellectual Property Organisation (OAPI) Region: Problems and Prospects

Co-Chair, Joelle Dountio Ofimboudem, University of Pretoria, Faculty of Law, 2013-2016

Intellectual property and the public interest: A comparative study of technology transfer laws and policy options for sub-Saharan African countries

Peer Review

African Journal of AIDS Research Asia Pacific Journal of Public Health Boston Medical Journal Globalization and Health Journal of Public Health Policy Oxford University Press Bulletin of the World Health Organization Yale Journal of Health Policy, Law, and Ethics New England Journal of Medicine Journal of African Law Journal of Health Politics, Policy and Law Journal of Generic Medicines Journal of Pharmaceutical Practice & Policy Stanford Journal of Law, Science & Policy Journal of the International AIDS Society Health and Human Rights Journal Politics of Medicine Review of International Political Economy UNDP Publications (various) AIDS Fond Grant Proposals (2014 Eliminating Intellectual Property Barriers) Open Society Foundation Grant Proposals (IP and A2M proposals) Canadian Yearbook on Human Rights Yale Journal of Health Policy, Law & Ethics The British Medical Journal

University: Search Committee, Chair of Department of Cultures, Societies and Global Studies 2016 Faculty Senate Administrator Evaluation Oversight subcommittee 2014-15 Tenure and Promotion Committee, Philosophy Dept. 2012 Founding Member, Global Health Initiative Core Group (Policy Pillar) 2011-14 Faculty Search Committee Member, Global Health/NTD Initiative 2011-13 Founding member, Health Policy and Law Program 2011-12 Teaching Excellence Committee 2011-13 Board of Directors, Women’s Studies Program 2004-06

Practice Oriented Education Conference Committee 2000-01 Advisory Group 2001-03 ACE Interest Group in Experiential Learning 1996-98 Ad hoc University Committee, Office of the Ombudsperson, Hate Crimes 1993 Department of Justice:

49

Community Advocacy Education: Building Safe and Healthy Neighborhoods (Dec. 4, 2000) Law School: Law, Culture, and Difference Ad Hoc Task Force: Law, Culture, and Difference 1991. Faculty Facilitator for Small-Group Discussions (1991-1998).

Supervision of LCD groups, 2000, 2001, 2002, 2004, 2005, 2006, 2007, 2010 Panel Presentations - "Juror-Decision-Making," Feb. 18, 1992; "Dealing with Difference: Dilemmas in Immigration - Visions of Assimilation vs. Images of Cultural Pluralism," November 2, 1995. "Cognitive Structure of Prejudice and Master-Stories of Race and Gender in Sexual Harassment," Sept. 1, 1994.

Legal Skills in Social Context

Co-Supervising Attorney, 2012-13, Identifying the “Right” for Disabled Persons in China Supervising Attorney, 2013-14, Wuhan U., Disability Rights

Co-operative Legal Education Program Panel Presentation, "Supervision-on-the-Job," 1990-1992. Presentation, "Professional Values, Lawyering Roles, and Legal Culture," 1990-1993. Co-op Residency Program, 1990-1992, 1999.

Pathways to Practice Legal Ethics and Professionalism on Co-op and Beyond, May 2012.

Outcome Assessment Project, Board of Directors 2012 NU Class Visits and Guest Lectures Guest Lecture, Human Rights, Intellectual Property, and Access to Medicines, Global Health Law course, Northeastern University, February 13, 2017 Guest Lecture, NU Global Health course, Intellectual Property and Access to Medicines, March 28, 2016 Guest Lectures, Pharma Wars: Intellectual Property, Trade and Access to Medicines, NU Chemistry of Tropical Disease and NU Global Health courses, March 25, 2013. Guest Reviewer, Grand Rounds, Civil Rights and Restorative Justice (Margaret Burnham’s class), NUSL, August 7, 2012 Guest Lecture, Introduction to IP: Alternative Perspectives, Intro to IP course, Nov. 7, 2011; Oct. 25, 2012; July 10, 2013, October 7, 2013; October 16, 2014; September 30, 2015; July 5, 2016; June 29, 2017, November 7, 2017, October 11, 2018 Guest Lecture, The Role of Patents and Data Monopolies on Access to Medicines, Drug Law and Policy course, March 12, 2012 NUSL, Comparative Constitutional Law class, Right to Health, March 28, 2007

Committees

Academic and Student Life Committee 2018-19 Appointments Committee 2012-13 Experiential Education Committee 2012-13, Chair 2013-14

50

Law, Culture, and Difference Committee, 1992-93, 1994-95 Curriculum Committee, 1988-92, 1994-97, 2001-02, 2004-05 Committee Against Institutional Racism, 1989-93; 1999-2003; 2013-14, 2017-19; Chair 1997-98, 2014-2019 Library Committee, 1991-92 Co-op Committee, 1989-91 Public Interest Requirement Committee, 1994-97 Ad Hoc Committee on Merit Pay Policy, 1998-2001 (Chair 2001) Ad Hoc Committee on Academic Support, 1987- 2003 Committee on Teaching Effective, Chair 1997-99 Task Force on Bar Pass Rate 2000-03 Tenure and Promotion Committee 2000-01, 2008-2009 (Chair), 2009-12, 2017-2018 Upper-Level Rigorous Writing Requirement Committee 2003-07, 2008-10 (Chair), 2011-12, 2016-

LLM Admissions Committee 2014-15 Global Law Committee 2014-15, Chair 2015-16

Ad hoc Committee on First Year Research and Writing 2005 Ad hoc Committee on Experiential Learning 2005 Student Organizations and Competitions

Faculty Advisory, Jessup Moot Court 2018-19 Coach, ABA Judicial Clerkship Program 2017 Coach, Counseling Competition: seventh place national finish, 2011-12

Faculty Advisor, Moot Court Society, 1990-1992 Faculty Advisor, Latino/a Law Students Association, 1990-1992 Faculty Advisor, Disability Law Caucus, 1994-96 Faculty Advisor, NUSL Student Global AIDS Campaign, 2002-2009 COMMUNITY SERVICE:

Consultation and Training - Office for Civil Rights, U.S. Dept. of Education: Interest- Based Negotiation Theory and Practice (1995, 1998)

Codman Square Neighborhood Council, Housing Comm. 1991-1992 Dorchester Central America Action Committee, 1988-1994

Host multiple visitors from S. Africa, 1997-2006

MEMBERSHIPS IN PROFESSIONAL ORGANIZATIONS: American Bar Association, 1991-present Legal Writing Institute, 1988-2005 AALS Clinical Law Section, 1988-2005 Clinical Legal Education Association, 1991-2005 Northeast Clinical Law Teachers, 1984-present Coordinator of Discussion Group, 1990-92 Faculty Discussion Group - Critical Race Theory 1994-2000 Faculty Discussion Group - Addressing Issues of Difference in Law Teaching 1995-96.

Board of Directors, Massachusetts Lawyers Guild, 1998-2000 HONORS AND APPOINTMENTS

Faculty Appreciation Award Dec. 2000. Public Policy Distinguished Professor 1998-99

RESUME-2017